{"atlas_id":"pmmr-mucinous-colon","collection_sha256":"3fca89bcd6ddfad82834ec909e6075042174620c6c5e8507621e2ed7775629c4","coverage_summary":{"coordinate_artifacts":50,"coordinate_priority_count":50,"coordinate_states":{"metadata-only-not-prioritized":135,"reused":50},"metadata_available":182,"metadata_snapshots":183,"metadata_unavailable":3,"retained_targets":185,"targets_with_experimental_structure":14,"targets_without_uniprot_accession":0},"failures":[{"failure":{"code":"network_error","message":"Request failed for alphafold-skill: HTTPError"},"target_id":"T-ENSG00000181143","target_symbol":"MUC16"},{"failure":{"code":"accession-model-mismatch","message":"AFDB returned no monomer prediction matching Q99102; returned models: AF-Q99102-12-F1, AF-Q99102-13-F1"},"target_id":"T-ENSG00000145113","target_symbol":"MUC4"},{"failure":{"code":"network_error","message":"Request failed for alphafold-skill: HTTPError"},"target_id":"T-ENSG00000169876","target_symbol":"MUC17"}],"generated_at":"2026-09-04","records":[{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":344,"sequence_length":344,"sequence_sha256":"17a1c619e0eadf450f0fa212b4a084121252ad7f7ff798bd3b217f0b2a94f49f","sequence_start":1,"source_sequence_checksum":"0f2b173fd1004f4b38a6e98aea76baa9","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":{"bytes":315404,"format":"mmcif","sha256":"9ce3022af9062ab2f5c77bae99e4db64f503df74e787e35bc6e000b535edc133","storage":"external-artifact-root"},"priority_selected":true,"retrieved_at":"2026-09-04","source_url":"https://alphafold.ebi.ac.uk/files/AF-P40199-F1-model_v6.cif","state":"reused","transport":"trusted cifUrl file download"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":1,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P40199-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P40199-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P40199-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":4464,"format":"json","sha256":"a0c3e7c63a4430f5e781d82ac639d9a03e59c9786ef6f90046a9460986525dce","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.015,"fraction_plddt_low":0.041,"fraction_plddt_very_high":0.823,"fraction_plddt_very_low":0.122,"global_plddt":88.19,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P40199-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2022-02-23"},"source_url":"https://alphafold.ebi.ac.uk/entry/P40199","structure_class":"predicted target model","structure_id":"S-AF-P40199-F1","structure_resource_rank":20,"structure_tier":"structure-b","target_id":"T-ENSG00000086548","target_symbol":"CEACAM6","uniprot_accession":"P40199"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":314,"sequence_length":314,"sequence_sha256":"e5d527336d82e9309b5ea19a32a85ad410a303db94b245801462e791abd1623c","sequence_start":1,"source_sequence_checksum":"f987c1840f7402f56e2d0974fd8692dc","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":{"bytes":294092,"format":"mmcif","sha256":"06528ce657c4afae48983bf85ed5735345b094724a91c33ac3f0eab73d8f423e","storage":"external-artifact-root"},"priority_selected":true,"retrieved_at":"2026-09-04","source_url":"https://alphafold.ebi.ac.uk/files/AF-P16422-F1-model_v6.cif","state":"reused","transport":"trusted cifUrl file download"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":2,"experimental_structure_ids":["S-RCSB-6I07"],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P16422-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P16422-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P16422-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":2346,"format":"json","sha256":"557a697e610afd084198a7a480b2b742f5b5c979e1bf61a03a310a5ee6f5f7ae","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.21,"fraction_plddt_low":0.099,"fraction_plddt_very_high":0.656,"fraction_plddt_very_low":0.035,"global_plddt":87.19,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P16422-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2007-11-13"},"source_url":"https://alphafold.ebi.ac.uk/entry/P16422","structure_class":"predicted target model","structure_id":"S-AF-P16422-F1","structure_resource_rank":4,"structure_tier":"structure-a","target_id":"T-ENSG00000119888","target_symbol":"EPCAM","uniprot_accession":"P16422"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":220,"sequence_length":220,"sequence_sha256":"0ba9b6b5e9b4d156e81521db8fb4d3e7cc60b100b6cbca960bdfd1c14ccf5b68","sequence_start":1,"source_sequence_checksum":"a713c34d81a8ae5f793394403ca61f1b","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":{"bytes":200977,"format":"mmcif","sha256":"b18fcad07ffc7a09eb32974b0a4bd3c14c6eef7dedccae8d8aa3e7ce2d0e6fa1","storage":"external-artifact-root"},"priority_selected":true,"retrieved_at":"2026-09-04","source_url":"https://alphafold.ebi.ac.uk/files/AF-O15551-F1-model_v6.cif","state":"reused","transport":"trusted cifUrl file download"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":3,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-O15551-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-O15551-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-O15551-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":2134,"format":"json","sha256":"b612a764a12fc0075ef1ee9fab74e852410c6e82a8e5d3054d304f3fc0b65eec","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.305,"fraction_plddt_low":0.136,"fraction_plddt_very_high":0.473,"fraction_plddt_very_low":0.086,"global_plddt":81.56,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-O15551-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1998-01-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/O15551","structure_class":"predicted target model","structure_id":"S-AF-O15551-F1","structure_resource_rank":28,"structure_tier":"structure-b","target_id":"T-ENSG00000165215","target_symbol":"CLDN3","uniprot_accession":"O15551"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":211,"sequence_length":211,"sequence_sha256":"4f83f5437022a2c7e7495ac78debcd29017fbed519d1d99c2e7513b34bbfa952","sequence_start":1,"source_sequence_checksum":"cd62c776037ade4290cdcf2b35c696ff","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":{"bytes":193200,"format":"mmcif","sha256":"91e21f1c4c7118d31d440d0a98ad5b61849725b9a777b4d9821e33ac3d48f1d0","storage":"external-artifact-root"},"priority_selected":true,"retrieved_at":"2026-09-04","source_url":"https://alphafold.ebi.ac.uk/files/AF-O95471-F1-model_v6.cif","state":"reused","transport":"trusted cifUrl file download"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":4,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-O95471-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-O95471-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-O95471-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":3885,"format":"json","sha256":"45b2dbb73a3f9297e2dfb66eca1027177fe9157cd941ac384585bb9eab439f89","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.246,"fraction_plddt_low":0.09,"fraction_plddt_very_high":0.555,"fraction_plddt_very_low":0.109,"global_plddt":82.62,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-O95471-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2010-11-02"},"source_url":"https://alphafold.ebi.ac.uk/entry/O95471","structure_class":"predicted target model","structure_id":"S-AF-O95471-F1","structure_resource_rank":29,"structure_tier":"structure-b","target_id":"T-ENSG00000181885","target_symbol":"CLDN7","uniprot_accession":"O95471"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":702,"sequence_length":702,"sequence_sha256":"1d589a5cfe8738ca20f7b2a4658dceebfb6741b489707df585481e190c2d462c","sequence_start":1,"source_sequence_checksum":"a4cb9e0ebeec52e351b5b20f648bab94","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":{"bytes":646651,"format":"mmcif","sha256":"22f009a7adfabaf1f7e1ad80ef6b6a51f1135056f9e51e33fddb8d9bd4ebd5f0","storage":"external-artifact-root"},"priority_selected":true,"retrieved_at":"2026-09-04","source_url":"https://alphafold.ebi.ac.uk/files/AF-P06731-F1-model_v6.cif","state":"reused","transport":"trusted cifUrl file download"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":5,"experimental_structure_ids":["S-RCSB-8BW0"],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P06731-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P06731-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P06731-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":6004,"format":"json","sha256":"704f8b280848add5e88f4eac0351719ae8ee0b1bc58495ad0033024ae69f27cf","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.197,"fraction_plddt_low":0.006,"fraction_plddt_very_high":0.717,"fraction_plddt_very_low":0.081,"global_plddt":87.12,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P06731-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2022-02-23"},"source_url":"https://alphafold.ebi.ac.uk/entry/P06731","structure_class":"predicted target model","structure_id":"S-AF-P06731-F1","structure_resource_rank":1,"structure_tier":"structure-a","target_id":"T-ENSG00000105388","target_symbol":"CEACAM5","uniprot_accession":"P06731"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":237,"sequence_length":237,"sequence_sha256":"52cd31489fca498b1fa74914c387351d8810a277639616ddbad78b9bb4ffb948","sequence_start":1,"source_sequence_checksum":"a4d37efd33c1c6e6a6dae32ec5dcf50d","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":{"bytes":222022,"format":"mmcif","sha256":"6445390de5d7109c8038b0e687b961f0f8f8ad3ecf9c0bc01d5a18de81e4e525","storage":"external-artifact-root"},"priority_selected":true,"retrieved_at":"2026-09-04","source_url":"https://alphafold.ebi.ac.uk/files/AF-P19075-F1-model_v6.cif","state":"reused","transport":"trusted cifUrl file download"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":6,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P19075-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P19075-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P19075-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":2172,"format":"json","sha256":"b61c82d04d07643adba1f56854cab726f989025726ec947f6e619c2328fcebea","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.316,"fraction_plddt_low":0.034,"fraction_plddt_very_high":0.603,"fraction_plddt_very_low":0.046,"global_plddt":87.5,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P19075-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1990-11-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/P19075","structure_class":"predicted target model","structure_id":"S-AF-P19075-F1","structure_resource_rank":31,"structure_tier":"structure-c","target_id":"T-ENSG00000127324","target_symbol":"TSPAN8","uniprot_accession":"P19075"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":209,"sequence_length":209,"sequence_sha256":"8cb61c933367dd678b240bd214da8f4c46fa63507dd8f4bbdb561fc9c1ce0ba4","sequence_start":1,"source_sequence_checksum":"445d44ec49c50ab24adc29ae4338ef57","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":{"bytes":190531,"format":"mmcif","sha256":"70e05aab4bfa66ddd3dbad34ff37f27fef898ef72be37fef9cd3900d1e32b4b8","storage":"external-artifact-root"},"priority_selected":true,"retrieved_at":"2026-09-04","source_url":"https://alphafold.ebi.ac.uk/files/AF-O14493-F1-model_v6.cif","state":"reused","transport":"trusted cifUrl file download"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":7,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-O14493-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-O14493-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-O14493-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":2112,"format":"json","sha256":"118a290a1fd1cbe3329f67b27ad80ccc4db019db98ebdb66ef520bb09753cee8","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.297,"fraction_plddt_low":0.105,"fraction_plddt_very_high":0.545,"fraction_plddt_very_low":0.053,"global_plddt":84.56,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-O14493-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1998-01-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/O14493","structure_class":"predicted target model","structure_id":"S-AF-O14493-F1","structure_resource_rank":25,"structure_tier":"structure-b","target_id":"T-ENSG00000189143","target_symbol":"CLDN4","uniprot_accession":"O14493"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":882,"sequence_length":882,"sequence_sha256":"6c2a333136e50ec3440f42cf6abea8d429a38b758d97b3f3610f96b0e25a1d9d","sequence_start":1,"source_sequence_checksum":"b61d2a33e504f9bc8257662a18aff76e","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":{"bytes":801131,"format":"mmcif","sha256":"e5470463cd0383a405b88bbed380a485c36b1e2f85adb1e159562164498f23c7","storage":"external-artifact-root"},"priority_selected":true,"retrieved_at":"2026-09-04","source_url":"https://alphafold.ebi.ac.uk/files/AF-P12830-F1-model_v6.cif","state":"reused","transport":"trusted cifUrl file download"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":8,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P12830-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P12830-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P12830-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":6555,"format":"json","sha256":"a3f825076e1244d94ad8fda9be3abafe078ff88ae312e7264888f1ad125af134","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.287,"fraction_plddt_low":0.084,"fraction_plddt_very_high":0.467,"fraction_plddt_very_low":0.162,"global_plddt":79.19,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P12830-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1993-07-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/P12830","structure_class":"predicted target model","structure_id":"S-AF-P12830-F1","structure_resource_rank":34,"structure_tier":"structure-c","target_id":"T-ENSG00000039068","target_symbol":"CDH1","uniprot_accession":"P12830"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":512,"sequence_length":512,"sequence_sha256":"6ccdfe078e8887becb02b25de1cc888d236aa8335ae3559acb65bbc51e791098","sequence_start":1,"source_sequence_checksum":"f314a4b356ed7fb6903e2c8ea341acd4","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":{"bytes":450410,"format":"mmcif","sha256":"a4741cdd287ff677155230b23768790cac375a18da25d66f17002288f2970efe","storage":"external-artifact-root"},"priority_selected":true,"retrieved_at":"2026-09-04","source_url":"https://alphafold.ebi.ac.uk/files/AF-Q9H3R2-F1-model_v6.cif","state":"reused","transport":"trusted cifUrl file download"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":9,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q9H3R2-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q9H3R2-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q9H3R2-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":5091,"format":"json","sha256":"1d00a29bb9d8ba0df7b637771fa7e3711d5dbb2f1a38fd4bfe0430eca654e719","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.213,"fraction_plddt_low":0.17,"fraction_plddt_very_high":0.285,"fraction_plddt_very_low":0.332,"global_plddt":67.06,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q9H3R2-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2014-05-14"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q9H3R2","structure_class":"predicted target model","structure_id":"S-AF-Q9H3R2-F1","structure_resource_rank":22,"structure_tier":"structure-b","target_id":"T-ENSG00000173702","target_symbol":"MUC13","uniprot_accession":"Q9H3R2"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":1055,"sequence_length":1055,"sequence_sha256":"0e2a4212efe4db1230afb680c18df3d12accbe13c325d91ac006a87635d9d000","sequence_start":1,"source_sequence_checksum":"8499cbd3d88427da406f6feea6623e42","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":{"bytes":986752,"format":"mmcif","sha256":"744fd20488dbb636c1b81d3475d42f84d096dfe75d7af3e8b9765ad1ca1cc09d","storage":"external-artifact-root"},"priority_selected":true,"retrieved_at":"2026-09-04","source_url":"https://alphafold.ebi.ac.uk/files/AF-P29323-F1-model_v6.cif","state":"reused","transport":"trusted cifUrl file download"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":10,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P29323-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P29323-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P29323-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":10704,"format":"json","sha256":"77387eabd1538f413720479325af4946c1fa6ebfe4bb688327c9203b083db6be","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.309,"fraction_plddt_low":0.062,"fraction_plddt_very_high":0.48,"fraction_plddt_very_low":0.15,"global_plddt":80.0,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P29323-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2005-09-27"},"source_url":"https://alphafold.ebi.ac.uk/entry/P29323","structure_class":"predicted target model","structure_id":"S-AF-P29323-F1","structure_resource_rank":26,"structure_tier":"structure-b","target_id":"T-ENSG00000133216","target_symbol":"EPHB2","uniprot_accession":"P29323"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":855,"sequence_length":855,"sequence_sha256":"b263b22b3360761991316e48cb14cbf385b45dfebf9f369fcadc77201ad72e9e","sequence_start":1,"source_sequence_checksum":"4effc914e417e9a3f1f045bdf827bb38","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":{"bytes":777555,"format":"mmcif","sha256":"c31cb49085f64e86c9eab8944b7933a16163218c8ae3f9ae2c2186808dfc7640","storage":"external-artifact-root"},"priority_selected":true,"retrieved_at":"2026-09-04","source_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y5Y6-F1-model_v6.cif","state":"reused","transport":"trusted cifUrl file download"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":11,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y5Y6-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y5Y6-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y5Y6-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":3433,"format":"json","sha256":"08e8e3f5a0798b99353fd3f6c266d23df99484f4ee18c14704e957f0d2a6c7d4","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.473,"fraction_plddt_low":0.117,"fraction_plddt_very_high":0.339,"fraction_plddt_very_low":0.071,"global_plddt":80.88,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q9Y5Y6-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2000-05-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q9Y5Y6","structure_class":"predicted target model","structure_id":"S-AF-Q9Y5Y6-F1","structure_resource_rank":41,"structure_tier":"structure-c","target_id":"T-ENSG00000149418","target_symbol":"ST14","uniprot_accession":"Q9Y5Y6"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":783,"sequence_length":783,"sequence_sha256":"7b56cff5f070e4c7e55714b1f98b39f2db4cb07561e706939bd44fe5dabee125","sequence_start":1,"source_sequence_checksum":"1b9bf98bad1a8b75d451f956f3d3aa24","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":{"bytes":703647,"format":"mmcif","sha256":"68cada9e62e5bde21f8de6206a8699fe11aa440fa496a785ffb5ec7fdb2fb72f","storage":"external-artifact-root"},"priority_selected":true,"retrieved_at":"2026-09-04","source_url":"https://alphafold.ebi.ac.uk/files/AF-Q68DV7-F1-model_v6.cif","state":"reused","transport":"trusted cifUrl file download"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":12,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q68DV7-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q68DV7-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q68DV7-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":12255,"format":"json","sha256":"811d3f0d088c73f7bdb6ff5d816936b567251fb99b78d492abbfc9fea0ed8bd2","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.152,"fraction_plddt_low":0.102,"fraction_plddt_very_high":0.149,"fraction_plddt_very_low":0.596,"global_plddt":55.5,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q68DV7-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2004-10-11"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q68DV7","structure_class":"predicted target model","structure_id":"S-AF-Q68DV7-F1","structure_resource_rank":43,"structure_tier":"structure-c","target_id":"T-ENSG00000108375","target_symbol":"RNF43","uniprot_accession":"Q68DV7"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":1255,"sequence_length":1255,"sequence_sha256":"5b9649b780e39a0610eaa2183ad064268ee6d69a66041595f91f93ca08444e66","sequence_start":1,"source_sequence_checksum":"7c2c426032f956a2a11c259cd44b19e4","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":{"bytes":1051455,"format":"mmcif","sha256":"154bd1369b41fd836d6b36c9caf4f1490d343116ffc9958443678e22d369ec25","storage":"external-artifact-root"},"priority_selected":true,"retrieved_at":"2026-09-04","source_url":"https://alphafold.ebi.ac.uk/files/AF-P15941-F1-model_v6.cif","state":"reused","transport":"trusted cifUrl file download"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":13,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P15941-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P15941-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P15941-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":41953,"format":"json","sha256":"630cb055f20d28711015dee68f8879eaeafacf5e20d7aeb8853d3127568e7221","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.085,"fraction_plddt_low":0.185,"fraction_plddt_very_high":0.02,"fraction_plddt_very_low":0.71,"global_plddt":47.41,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P15941-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2010-05-18"},"source_url":"https://alphafold.ebi.ac.uk/entry/P15941","structure_class":"predicted target model","structure_id":"S-AF-P15941-F1","structure_resource_rank":17,"structure_tier":"structure-b","target_id":"T-ENSG00000185499","target_symbol":"MUC1","uniprot_accession":"P15941"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":832,"sequence_length":832,"sequence_sha256":"8ad9d4c358f008df47e62a88f99fbc7dc1b19bb8f53049f37478969fdf0059c4","sequence_start":1,"source_sequence_checksum":"550d7a557ebee4cdbe03dff8721a4fb2","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":{"bytes":759029,"format":"mmcif","sha256":"af9fa937baa244668c99fad5bd1e2381b88fddf51575468f8ab42fdf8acdd324","storage":"external-artifact-root"},"priority_selected":true,"retrieved_at":"2026-09-04","source_url":"https://alphafold.ebi.ac.uk/files/AF-Q12864-F1-model_v6.cif","state":"reused","transport":"trusted cifUrl file download"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":14,"experimental_structure_ids":["S-RCSB-6ULM"],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q12864-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q12864-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q12864-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":3361,"format":"json","sha256":"630413d60e8d750ee518aa10cfc62054f1d68d2c7c7c309adbf593cf56dd4852","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.316,"fraction_plddt_low":0.025,"fraction_plddt_very_high":0.597,"fraction_plddt_very_low":0.061,"global_plddt":86.69,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q12864-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2010-10-05"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q12864","structure_class":"predicted target model","structure_id":"S-AF-Q12864-F1","structure_resource_rank":14,"structure_tier":"structure-b","target_id":"T-ENSG00000079112","target_symbol":"CDH17","uniprot_accession":"Q12864"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":319,"sequence_length":319,"sequence_sha256":"215f76c7b8f0b91d349f701c41d9d579dad822a42ccfb1031207b3ed85cc30c3","sequence_start":1,"source_sequence_checksum":"8660c77ab47b21211479d0156ddd5125","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":{"bytes":302140,"format":"mmcif","sha256":"8d2c6bec27f4ad144cd4153df66eef00a26cdf604b5f66ae6eb1184dd124594e","storage":"external-artifact-root"},"priority_selected":true,"retrieved_at":"2026-09-04","source_url":"https://alphafold.ebi.ac.uk/files/AF-Q99795-F1-model_v6.cif","state":"reused","transport":"trusted cifUrl file download"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":15,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q99795-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q99795-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q99795-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":2347,"format":"json","sha256":"eacc2455941b692333bd071cec5bd98478f4cce63bebc6cd602614b8e883d20a","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.107,"fraction_plddt_low":0.119,"fraction_plddt_very_high":0.677,"fraction_plddt_very_low":0.097,"global_plddt":85.0,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q99795-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1997-05-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q99795","structure_class":"predicted target model","structure_id":"S-AF-Q99795-F1","structure_resource_rank":16,"structure_tier":"structure-b","target_id":"T-ENSG00000143167","target_symbol":"GPA33","uniprot_accession":"Q99795"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":1210,"sequence_length":1210,"sequence_sha256":"dbb4583267ad40a7dfd854ee3c44ce4be38e137d0570e3eb76cf1854a74e7246","sequence_start":1,"source_sequence_checksum":"99d03b567dbcdd7fb0dd21fb40d5d283","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":{"bytes":1127973,"format":"mmcif","sha256":"485413c9edb379204b45cae0191e4d44aa136d160da78ccbed69a4678f8e392f","storage":"external-artifact-root"},"priority_selected":true,"retrieved_at":"2026-09-04","source_url":"https://alphafold.ebi.ac.uk/files/AF-P00533-F1-model_v6.cif","state":"reused","transport":"trusted cifUrl file download"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":16,"experimental_structure_ids":["S-RCSB-1YY9"],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P00533-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P00533-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P00533-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":12049,"format":"json","sha256":"6f0b5ba320021a23fe02e1f93bd92dfd4ce0871cdc91240fac8f5ce508ca8226","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.233,"fraction_plddt_low":0.065,"fraction_plddt_very_high":0.474,"fraction_plddt_very_low":0.228,"global_plddt":75.94,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P00533-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1997-11-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/P00533","structure_class":"predicted target model","structure_id":"S-AF-P00533-F1","structure_resource_rank":2,"structure_tier":"structure-a","target_id":"T-ENSG00000146648","target_symbol":"EGFR","uniprot_accession":"P00533"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":1255,"sequence_length":1255,"sequence_sha256":"a5f256fc653515d110f6dd48ad55b8ea21bf6d45af33b7f5c182c6c31455b636","sequence_start":1,"source_sequence_checksum":"d89a90920775435179a0d5281a800f78","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":{"bytes":1161470,"format":"mmcif","sha256":"0314dc759af7a57008603337718a197744022b523a723ceb2de16a4d49db1a02","storage":"external-artifact-root"},"priority_selected":true,"retrieved_at":"2026-09-04","source_url":"https://alphafold.ebi.ac.uk/files/AF-P04626-F1-model_v6.cif","state":"reused","transport":"trusted cifUrl file download"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":17,"experimental_structure_ids":["S-RCSB-1N8Z"],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P04626-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P04626-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P04626-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":20807,"format":"json","sha256":"8f82f949f4cdedf1c51041a5ff7ef706aaf9df81b520520d7ff75d930257c275","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.246,"fraction_plddt_low":0.086,"fraction_plddt_very_high":0.422,"fraction_plddt_very_low":0.245,"global_plddt":74.0,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P04626-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1987-08-13"},"source_url":"https://alphafold.ebi.ac.uk/entry/P04626","structure_class":"predicted target model","structure_id":"S-AF-P04626-F1","structure_resource_rank":3,"structure_tier":"structure-a","target_id":"T-ENSG00000141736","target_symbol":"ERBB2","uniprot_accession":"P04626"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":1342,"sequence_length":1342,"sequence_sha256":"17edac2fa022b912a92821032c8b6d4a300cd07a4c81906cb7faa2b94996f600","sequence_start":1,"source_sequence_checksum":"4a991f48f32cfa86f990aab1b861bed4","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":{"bytes":1250463,"format":"mmcif","sha256":"43f83dca3851ad30fd7361d41b86d2b48ac31a1e1b5d4c17d595558028a300e2","storage":"external-artifact-root"},"priority_selected":true,"retrieved_at":"2026-09-04","source_url":"https://alphafold.ebi.ac.uk/files/AF-P21860-F1-model_v6.cif","state":"reused","transport":"trusted cifUrl file download"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":18,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P21860-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P21860-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P21860-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":15343,"format":"json","sha256":"609c2a18bee563186204d76ac0d1248126fc797377ce32b2bc250f43e3b85c07","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.189,"fraction_plddt_low":0.044,"fraction_plddt_very_high":0.47,"fraction_plddt_very_low":0.297,"global_plddt":72.44,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P21860-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1991-05-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/P21860","structure_class":"predicted target model","structure_id":"S-AF-P21860-F1","structure_resource_rank":23,"structure_tier":"structure-b","target_id":"T-ENSG00000065361","target_symbol":"ERBB3","uniprot_accession":"P21860"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":630,"sequence_length":630,"sequence_sha256":"85dadcd8397d68d34972e3278f0fc47b51659537c8c6ba3e62243aee293108b3","sequence_start":1,"source_sequence_checksum":"159ccc954a27c66b415dfac89f39b630","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":{"bytes":567801,"format":"mmcif","sha256":"6633b68d7d8bcdb47e5dedb88f3fa7378714daa7325bfd018d30fef2381a6b48","storage":"external-artifact-root"},"priority_selected":true,"retrieved_at":"2026-09-04","source_url":"https://alphafold.ebi.ac.uk/files/AF-Q13421-F1-model_v6.cif","state":"reused","transport":"trusted cifUrl file download"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":19,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q13421-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q13421-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q13421-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":11117,"format":"json","sha256":"05a23d20c0c76c67930ed1e9bbf1945427fe27fc992d0bb5f25ad288dc42bc02","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.395,"fraction_plddt_low":0.046,"fraction_plddt_very_high":0.394,"fraction_plddt_very_low":0.165,"global_plddt":78.62,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q13421-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2006-10-17"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q13421","structure_class":"predicted target model","structure_id":"S-AF-Q13421-F1","structure_resource_rank":19,"structure_tier":"structure-b","target_id":"T-ENSG00000102854","target_symbol":"MSLN","uniprot_accession":"Q13421"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":211,"sequence_length":211,"sequence_sha256":"fc771ec8596f2cab6950a15ec5eebdc7dc4da3542c8c0d52145ee1795a6bb35b","sequence_start":1,"source_sequence_checksum":"fc088de5faf46e844eaf974705a6993f","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":{"bytes":196137,"format":"mmcif","sha256":"e9a5ed32faadeb74d8c3862fe0820f795d32332b197775f121f72992abb5ce24","storage":"external-artifact-root"},"priority_selected":true,"retrieved_at":"2026-09-04","source_url":"https://alphafold.ebi.ac.uk/files/AF-O95832-F1-model_v6.cif","state":"reused","transport":"trusted cifUrl file download"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":20,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-O95832-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-O95832-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-O95832-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":2115,"format":"json","sha256":"215dc3dc78c4c76a4b930418e423c225a88762fc4e40b1530a2fd05f8bdb6c7e","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.261,"fraction_plddt_low":0.156,"fraction_plddt_very_high":0.55,"fraction_plddt_very_low":0.033,"global_plddt":84.75,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-O95832-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1999-05-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/O95832","structure_class":"predicted target model","structure_id":"S-AF-O95832-F1","structure_resource_rank":37,"structure_tier":"structure-c","target_id":"T-ENSG00000163347","target_symbol":"CLDN1","uniprot_accession":"O95832"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":492,"sequence_length":492,"sequence_sha256":"cc16edbc0d573ad46f7962c2fe3e99ac43b7c21d34fb1928ce67f24cc951f022","sequence_start":1,"source_sequence_checksum":"cde80c443f573cb33f637b0482e4c50f","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":21,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P11166-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P11166-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P11166-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":2734,"format":"json","sha256":"6074d46ae5561face1ccbaf809f685f7e565ef2dd2278c02b9663287776184e4","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.199,"fraction_plddt_low":0.012,"fraction_plddt_very_high":0.74,"fraction_plddt_very_low":0.049,"global_plddt":90.25,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P11166-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2006-10-03"},"source_url":"https://alphafold.ebi.ac.uk/entry/P11166","structure_class":"predicted target model","structure_id":"S-AF-P11166-F1","structure_resource_rank":61,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000117394","target_symbol":"SLC2A1","uniprot_accession":"P11166"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":1179,"sequence_length":1179,"sequence_sha256":"a260ea91bf79978ff722e78a508757bebcf20dc67aadd4ed02e3f842e16ca788","sequence_start":1,"source_sequence_checksum":"5eda249994d919aa640236a2d5fab629","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":22,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P38570-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P38570-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P38570-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":4059,"format":"json","sha256":"9ec7a474bf6cc4b721c1259d4775330e917144991a4c8aab14a25be4ed8bea06","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.455,"fraction_plddt_low":0.135,"fraction_plddt_very_high":0.34,"fraction_plddt_very_low":0.07,"global_plddt":80.62,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P38570-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2009-04-14"},"source_url":"https://alphafold.ebi.ac.uk/entry/P38570","structure_class":"predicted target model","structure_id":"S-AF-P38570-F1","structure_resource_rank":64,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000083457","target_symbol":"ITGAE","uniprot_accession":"P38570"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":1390,"sequence_length":1390,"sequence_sha256":"cc24e8701a5717fd1fa418174adb3b6cbaeae8a76f78b33a995f44c5bb394056","sequence_start":1,"source_sequence_checksum":"ee0753c4f68e188bddb0c66890beee23","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":{"bytes":1316484,"format":"mmcif","sha256":"ebb068ef35cb84d269525997f9a30f0ee555d4cd9388b7df1c772b033ff8c59f","storage":"external-artifact-root"},"priority_selected":true,"retrieved_at":"2026-09-04","source_url":"https://alphafold.ebi.ac.uk/files/AF-P08581-F1-model_v6.cif","state":"reused","transport":"trusted cifUrl file download"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":23,"experimental_structure_ids":["S-RCSB-4K3J"],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P08581-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P08581-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P08581-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":11795,"format":"json","sha256":"01bdedbc1ee4289b1b17ddb453a556699e897c7a0d75eb5a83c7fd639154e022","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.355,"fraction_plddt_low":0.076,"fraction_plddt_very_high":0.431,"fraction_plddt_very_low":0.139,"global_plddt":79.25,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P08581-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2009-07-07"},"source_url":"https://alphafold.ebi.ac.uk/entry/P08581","structure_class":"predicted target model","structure_id":"S-AF-P08581-F1","structure_resource_rank":5,"structure_tier":"structure-a","target_id":"T-ENSG00000105976","target_symbol":"MET","uniprot_accession":"P08581"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":303,"sequence_length":303,"sequence_sha256":"84332804df412712497a828955ceb3a10fb3fbfb970341032a8109e2422b9fad","sequence_start":1,"source_sequence_checksum":"3048511aeb0024bc664ad291cd1eea79","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":24,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P05026-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P05026-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P05026-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":4442,"format":"json","sha256":"6363cd9dd1ad8d839916ea7fc615bc809d0ff3686d973bc926c92050001063e9","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.198,"fraction_plddt_low":0.063,"fraction_plddt_very_high":0.736,"fraction_plddt_very_low":0.003,"global_plddt":89.56,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P05026-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1987-08-13"},"source_url":"https://alphafold.ebi.ac.uk/entry/P05026","structure_class":"predicted target model","structure_id":"S-AF-P05026-F1","structure_resource_rank":65,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000143153","target_symbol":"ATP1B1","uniprot_accession":"P05026"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":362,"sequence_length":362,"sequence_sha256":"5de81f208e7148a6c5163dc26042423d3e3fdd21b2eb3c95625b3a80f58583fb","sequence_start":1,"source_sequence_checksum":"81178d429f06ec0aa8142b707a4919a9","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":25,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P01889-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P01889-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P01889-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":2462,"format":"json","sha256":"2ff0a743b1a13f10b45e591901fbada2d907f4561c82c76ceca58476ba5a5f85","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.055,"fraction_plddt_low":0.052,"fraction_plddt_very_high":0.776,"fraction_plddt_very_low":0.116,"global_plddt":88.06,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P01889-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1991-02-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/P01889","structure_class":"predicted target model","structure_id":"S-AF-P01889-F1","structure_resource_rank":66,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000234745","target_symbol":"HLA-B","uniprot_accession":"P01889"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":381,"sequence_length":381,"sequence_sha256":"989a894cc61bee9971c93b7be051d4d3718d7955ce6e3bb5f2d157377072f96f","sequence_start":1,"source_sequence_checksum":"9646e3fe5aa2e9bb9988188b6498de9c","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":26,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P08174-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P08174-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P08174-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":16763,"format":"json","sha256":"1e396e6dde3183b5a48a94fb20fec2f75a041e69323bc50b97e447f5573af28d","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.013,"fraction_plddt_low":0.047,"fraction_plddt_very_high":0.651,"fraction_plddt_very_low":0.289,"global_plddt":78.25,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P08174-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2005-03-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/P08174","structure_class":"predicted target model","structure_id":"S-AF-P08174-F1","structure_resource_rank":67,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000196352","target_symbol":"CD55","uniprot_accession":"P08174"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":385,"sequence_length":385,"sequence_sha256":"e4c2f484f4707a731baa61ab7f43e808c778198b657912e6500659e0a7e30308","sequence_start":1,"source_sequence_checksum":"b2d3a053c12d34d9209189a97c8aa700","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":27,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P35613-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P35613-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P35613-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":8110,"format":"json","sha256":"4d72e3bb035ce69425ffb69607dcf3d99c4d23e5a77199a0caa295e7f08d6933","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.164,"fraction_plddt_low":0.078,"fraction_plddt_very_high":0.673,"fraction_plddt_very_low":0.086,"global_plddt":86.12,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P35613-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2004-08-31"},"source_url":"https://alphafold.ebi.ac.uk/entry/P35613","structure_class":"predicted target model","structure_id":"S-AF-P35613-F1","structure_resource_rank":68,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000172270","target_symbol":"BSG","uniprot_accession":"P35613"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":296,"sequence_length":296,"sequence_sha256":"f6909ab67f84bc41d8ef8976b6e5634ebcb9031613d297ac41e582c377b48728","sequence_start":1,"source_sequence_checksum":"2991837d7224dd528e45e3d8d09b87ab","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":28,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P04233-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P04233-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P04233-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":10084,"format":"json","sha256":"b1919afcf582e3b8305172693c73112cf13c60cd65f10a4c46f32fba84141e9d","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.284,"fraction_plddt_low":0.189,"fraction_plddt_very_high":0.257,"fraction_plddt_very_low":0.27,"global_plddt":69.94,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P04233-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2002-04-16"},"source_url":"https://alphafold.ebi.ac.uk/entry/P04233","structure_class":"predicted target model","structure_id":"S-AF-P04233-F1","structure_resource_rank":69,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000019582","target_symbol":"CD74","uniprot_accession":"P04233"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":913,"sequence_length":913,"sequence_sha256":"8668509c1c5a38917d30a46f023eded94584a129e7dac90b7e80fd4e56d943ac","sequence_start":1,"source_sequence_checksum":"9264bdf2992309a1eb17cacba71846a9","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":{"bytes":826998,"format":"mmcif","sha256":"84796010a79e2b27f2a080c0010ab18d5b7907d8a3e14707d537d09786b1d36c","storage":"external-artifact-root"},"priority_selected":true,"retrieved_at":"2026-09-04","source_url":"https://alphafold.ebi.ac.uk/files/AF-Q08345-F1-model_v6.cif","state":"reused","transport":"trusted cifUrl file download"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":29,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q08345-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q08345-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q08345-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":15392,"format":"json","sha256":"2df89bb821a6a37c9a5bc52f8794746978b82fcad7f1a4b5e28a625ed02a44e2","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.171,"fraction_plddt_low":0.044,"fraction_plddt_very_high":0.533,"fraction_plddt_very_low":0.252,"global_plddt":76.19,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q08345-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1995-02-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q08345","structure_class":"predicted target model","structure_id":"S-AF-Q08345-F1","structure_resource_rank":35,"structure_tier":"structure-c","target_id":"T-ENSG00000204580","target_symbol":"DDR1","uniprot_accession":"Q08345"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":630,"sequence_length":630,"sequence_sha256":"a5e0be8a99958752bb23ac1ad9cc11d2f70a195a87ba9879108527e694222761","sequence_start":1,"source_sequence_checksum":"3cdf73e02cabaaf17c27d69e53500a8e","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":30,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P08195-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P08195-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P08195-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":13710,"format":"json","sha256":"73d2dd0844982b5c46b0c0f92154ae9823f164f9d6615530dcf74353620dd2de","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.113,"fraction_plddt_low":0.014,"fraction_plddt_very_high":0.624,"fraction_plddt_very_low":0.249,"global_plddt":78.69,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P08195-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2009-09-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/P08195","structure_class":"predicted target model","structure_id":"S-AF-P08195-F1","structure_resource_rank":72,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000168003","target_symbol":"SLC3A2","uniprot_accession":"P08195"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":574,"sequence_length":574,"sequence_sha256":"0e3740730dd7a0bb4d2d5eb050d6f2e5ead1cdfa625f09f6a7ab65acc340055f","sequence_start":1,"source_sequence_checksum":"bbe8de5bb29ba879cb7b0b37bf678985","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":{"bytes":526490,"format":"mmcif","sha256":"23e1e44ffa940b23e4132673bcad67a8c2e9547c15507a3c086058639d8016dc","storage":"external-artifact-root"},"priority_selected":true,"retrieved_at":"2026-09-04","source_url":"https://alphafold.ebi.ac.uk/files/AF-P21589-F1-model_v6.cif","state":"reused","transport":"trusted cifUrl file download"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":31,"experimental_structure_ids":["S-RCSB-7BBJ","S-RCSB-9R0G"],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P21589-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P21589-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P21589-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":5357,"format":"json","sha256":"33d1fbf7f73318bbde22d001a85016d16aafd39c79f9c269bfc58bbd38c7137c","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.052,"fraction_plddt_low":0.017,"fraction_plddt_very_high":0.857,"fraction_plddt_very_low":0.073,"global_plddt":91.88,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P21589-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1991-05-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/P21589","structure_class":"predicted target model","structure_id":"S-AF-P21589-F1","structure_resource_rank":7,"structure_tier":"structure-a","target_id":"T-ENSG00000135318","target_symbol":"NT5E","uniprot_accession":"P21589"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":742,"sequence_length":742,"sequence_sha256":"e19d744d038c01b8cc22bd7b2f0f42db427460e1ae0c3c033bfda05a992057ff","sequence_start":1,"source_sequence_checksum":"f01d08ce2aabbb25c5abfcaf527e501e","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":32,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P16070-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P16070-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P16070-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":47852,"format":"json","sha256":"9b6582a8cfde6d14d2479ca1b090bd439677e74280f5e81a981cf962b117ffd2","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.028,"fraction_plddt_low":0.065,"fraction_plddt_very_high":0.21,"fraction_plddt_very_low":0.697,"global_plddt":53.25,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P16070-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2010-10-05"},"source_url":"https://alphafold.ebi.ac.uk/entry/P16070","structure_class":"predicted target model","structure_id":"S-AF-P16070-F1","structure_resource_rank":74,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000026508","target_symbol":"CD44","uniprot_accession":"P16070"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":323,"sequence_length":323,"sequence_sha256":"f337b2b4d3670cc9da5ce68671c1e4c1d5cbd6d6c9d04d0f76cffca42e43a1da","sequence_start":1,"source_sequence_checksum":"79047f5c4d2d5f81b5af88c78d0e4db4","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":{"bytes":300289,"format":"mmcif","sha256":"cd01517f16537afa583399eaef4645a1df8c143804f5efe770ad249b0fd51a7e","storage":"external-artifact-root"},"priority_selected":true,"retrieved_at":"2026-09-04","source_url":"https://alphafold.ebi.ac.uk/files/AF-P09758-F1-model_v6.cif","state":"reused","transport":"trusted cifUrl file download"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":33,"experimental_structure_ids":["S-RCSB-9PI9"],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P09758-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P09758-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P09758-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":2378,"format":"json","sha256":"f14d9f93811e8a16ff5262d5d162a3400e2ee1a0e6f87aedc4024e7c200f3143","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.155,"fraction_plddt_low":0.164,"fraction_plddt_very_high":0.594,"fraction_plddt_very_low":0.087,"global_plddt":82.69,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P09758-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2007-11-13"},"source_url":"https://alphafold.ebi.ac.uk/entry/P09758","structure_class":"predicted target model","structure_id":"S-AF-P09758-F1","structure_resource_rank":6,"structure_tier":"structure-a","target_id":"T-ENSG00000184292","target_symbol":"TACSTD2","uniprot_accession":"P09758"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":267,"sequence_length":267,"sequence_sha256":"de9a6cfaa5ba398a00340c981b0058f26010169f0f74ef672c695e4846b65416","sequence_start":1,"source_sequence_checksum":"5fe41c411d674256127f742e4e951ff8","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":34,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P27701-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P27701-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P27701-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":4174,"format":"json","sha256":"29f9c05a96194876850895060fcb8c1341b640c0c4e772e717139b73dfeef16d","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.266,"fraction_plddt_low":0.079,"fraction_plddt_very_high":0.652,"fraction_plddt_very_low":0.004,"global_plddt":88.31,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P27701-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1992-08-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/P27701","structure_class":"predicted target model","structure_id":"S-AF-P27701-F1","structure_resource_rank":77,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000085117","target_symbol":"CD82","uniprot_accession":"P27701"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":788,"sequence_length":788,"sequence_sha256":"871c82602ef83b96fc7e48abb1d783377410233b25a6bf2f2850d98965d21860","sequence_start":1,"source_sequence_checksum":"d58d208f4d290ed5bc4fd99e20986329","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":{"bytes":702126,"format":"mmcif","sha256":"0c08cd956911572e33519ddbb07d22d757e522f72bc2df4ede12b3581947b507","storage":"external-artifact-root"},"priority_selected":true,"retrieved_at":"2026-09-04","source_url":"https://alphafold.ebi.ac.uk/files/AF-P18564-F1-model_v6.cif","state":"reused","transport":"trusted cifUrl file download"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":35,"experimental_structure_ids":["S-RCSB-8TCG","S-RCSB-8TCG-RFD3-AB"],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P18564-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P18564-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P18564-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":6095,"format":"json","sha256":"70cdb62458ded16ad3eee3b27610be1343cefb2315f3162b128e1da211ed1464","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.454,"fraction_plddt_low":0.104,"fraction_plddt_very_high":0.39,"fraction_plddt_very_low":0.052,"global_plddt":82.88,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P18564-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2001-04-27"},"source_url":"https://alphafold.ebi.ac.uk/entry/P18564","structure_class":"predicted target model","structure_id":"S-AF-P18564-F1","structure_resource_rank":11,"structure_tier":"structure-b","target_id":"T-ENSG00000115221","target_symbol":"ITGB6","uniprot_accession":"P18564"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":1620,"sequence_length":1620,"sequence_sha256":"74716bef5c87821e4b00db1043b6b1f1b4e661f13f1fc7dc3e9b3ceb33ba71d9","sequence_start":1,"source_sequence_checksum":"638c4a64d52d6951aeba1a615d93068f","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":36,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UM73-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UM73-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UM73-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":4952,"format":"json","sha256":"a218a1d9f6e5dc83281e98c83e300350b91d201b69e970e583adafef2daccb2c","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.372,"fraction_plddt_low":0.153,"fraction_plddt_very_high":0.204,"fraction_plddt_very_low":0.271,"global_plddt":68.19,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q9UM73-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2010-05-18"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q9UM73","structure_class":"predicted target model","structure_id":"S-AF-Q9UM73-F1","structure_resource_rank":78,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000171094","target_symbol":"ALK","uniprot_accession":"Q9UM73"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":2555,"sequence_length":2555,"sequence_sha256":"13a0562d5e1bb03c7e093ac0b73b8eb15b6df7bb2298bfb6aed6ace9f6a50f77","sequence_start":1,"source_sequence_checksum":"3804777010fb8e332bdafeb7268cd14b","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":37,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P46531-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P46531-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P46531-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":6839,"format":"json","sha256":"5fb3a783498cd6225963bd55fe78ad239be60b2f21f85fa62489c864fe5b71b4","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.319,"fraction_plddt_low":0.386,"fraction_plddt_very_high":0.029,"fraction_plddt_very_low":0.266,"global_plddt":59.59,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P46531-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2008-09-23"},"source_url":"https://alphafold.ebi.ac.uk/entry/P46531","structure_class":"predicted target model","structure_id":"S-AF-P46531-F1","structure_resource_rank":79,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000148400","target_symbol":"NOTCH1","uniprot_accession":"P46531"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":510,"sequence_length":510,"sequence_sha256":"adb29ded2d895f7484cdd8537164d3dac86b553ca66b082eff33785181e79126","sequence_start":1,"source_sequence_checksum":"b915421788264c51471f8e4add9c68ff","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":{"bytes":479890,"format":"mmcif","sha256":"3562034a2c6727eab7b9aa891006443b82fc0ce4c349e0fc592f701c6c7c8785","storage":"external-artifact-root"},"priority_selected":true,"retrieved_at":"2026-09-04","source_url":"https://alphafold.ebi.ac.uk/files/AF-P49961-F1-model_v6.cif","state":"reused","transport":"trusted cifUrl file download"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":38,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P49961-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P49961-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P49961-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":14466,"format":"json","sha256":"63fcbc438571605fea7862864dde77706b76b5ca127c09b2d60342906c536fe5","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.135,"fraction_plddt_low":0.049,"fraction_plddt_very_high":0.784,"fraction_plddt_very_low":0.031,"global_plddt":91.0,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P49961-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1996-10-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/P49961","structure_class":"predicted target model","structure_id":"S-AF-P49961-F1","structure_resource_rank":44,"structure_tier":"structure-c","target_id":"T-ENSG00000138185","target_symbol":"ENTPD1","uniprot_accession":"P49961"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":507,"sequence_length":507,"sequence_sha256":"4cefddb471e4fa81075cb5a14ca59a3f498177df13692fc3b4c5e7c2a0666166","sequence_start":1,"source_sequence_checksum":"9b252669ceb64b74af845032edd4f708","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":39,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q01650-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q01650-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q01650-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":2753,"format":"json","sha256":"8ed63b054002d098138104454852a150ad008e2c5657a160be82ad8331a80797","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.349,"fraction_plddt_low":0.034,"fraction_plddt_very_high":0.562,"fraction_plddt_very_low":0.055,"global_plddt":85.88,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q01650-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2001-01-24"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q01650","structure_class":"predicted target model","structure_id":"S-AF-Q01650-F1","structure_resource_rank":80,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000103257","target_symbol":"SLC7A5","uniprot_accession":"Q01650"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":301,"sequence_length":301,"sequence_sha256":"19fad6122957287e994f5b674a6ed813fad5c4be3a60f4403e005ed2dbed0ffa","sequence_start":1,"source_sequence_checksum":"abe2cb4efdbde42fab6c00d84cb1a578","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":40,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q8TDQ0-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q8TDQ0-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q8TDQ0-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":4098,"format":"json","sha256":"4de1cff36024ae17cdb6e8a8d797d1f786cd2bbd45ad1df214e3610b5dc899bd","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.272,"fraction_plddt_low":0.249,"fraction_plddt_very_high":0.282,"fraction_plddt_very_low":0.196,"global_plddt":71.75,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q8TDQ0-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2010-11-02"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q8TDQ0","structure_class":"predicted target model","structure_id":"S-AF-Q8TDQ0-F1","structure_resource_rank":54,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000135077","target_symbol":"HAVCR2","uniprot_accession":"Q8TDQ0"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":369,"sequence_length":369,"sequence_sha256":"8fd6cd6e21332287f6b23e7564a64a9a42480cfcdd689e963e17997b806d1660","sequence_start":1,"source_sequence_checksum":"9c5c329adf266631e095217f605805b8","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":41,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P51686-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P51686-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P51686-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":4638,"format":"json","sha256":"db88644d1f2c04ba8a8e9c918b5a871e709ea7910e6d8f219b4d4a49dd824ec6","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.412,"fraction_plddt_low":0.043,"fraction_plddt_very_high":0.447,"fraction_plddt_very_low":0.098,"global_plddt":83.44,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P51686-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2006-09-05"},"source_url":"https://alphafold.ebi.ac.uk/entry/P51686","structure_class":"predicted target model","structure_id":"S-AF-P51686-F1","structure_resource_rank":81,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000173585","target_symbol":"CCR9","uniprot_accession":"P51686"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":602,"sequence_length":602,"sequence_sha256":"a69193e28b483478d78dd2a26eb76607fe5b7375c8a543976bc87874b0c17f41","sequence_start":1,"source_sequence_checksum":"b703a8db048e97ca7fd9534900e99c18","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":42,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q07065-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q07065-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q07065-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":2921,"format":"json","sha256":"646466ae35661e7dfb3c1f1b099162423340ee939ff79d3aa5dacbfdc841aaf3","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.35,"fraction_plddt_low":0.125,"fraction_plddt_very_high":0.346,"fraction_plddt_very_low":0.179,"global_plddt":75.5,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q07065-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2002-06-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q07065","structure_class":"predicted target model","structure_id":"S-AF-Q07065-F1","structure_resource_rank":82,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000136026","target_symbol":"CKAP4","uniprot_accession":"Q07065"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":1383,"sequence_length":1383,"sequence_sha256":"3f8119b9dfc7d5e59c2128dbfca6b4a8561e90be0d2f656053b993ca5adc180e","sequence_start":1,"source_sequence_checksum":"208314fd2f3f1cacd60d76ca9993ca61","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":43,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UHN6-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UHN6-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UHN6-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":8610,"format":"json","sha256":"a8ecf43445025fd7ab215ab3bb5efdc37079a3936addc7212e363716e3a1a244","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.156,"fraction_plddt_low":0.027,"fraction_plddt_very_high":0.764,"fraction_plddt_very_low":0.052,"global_plddt":89.56,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q9UHN6-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2000-05-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q9UHN6","structure_class":"predicted target model","structure_id":"S-AF-Q9UHN6-F1","structure_resource_rank":83,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000135048","target_symbol":"CEMIP2","uniprot_accession":"Q9UHN6"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":354,"sequence_length":354,"sequence_sha256":"1ce65b514b2da647edba33b17ba6587a73fde0645399710a68c43668c3e9bfcf","sequence_start":1,"source_sequence_checksum":"4adf59270764fe0ae91244785dfad70d","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":44,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P34810-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P34810-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P34810-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":8626,"format":"json","sha256":"970c627d5a0e9f8512688de3b6a833e9b1ba46fbdef550a846f383f845f9f301","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.068,"fraction_plddt_low":0.167,"fraction_plddt_very_high":0.483,"fraction_plddt_very_low":0.282,"global_plddt":73.19,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P34810-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2007-05-15"},"source_url":"https://alphafold.ebi.ac.uk/entry/P34810","structure_class":"predicted target model","structure_id":"S-AF-P34810-F1","structure_resource_rank":84,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000129226","target_symbol":"CD68","uniprot_accession":"P34810"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":567,"sequence_length":567,"sequence_sha256":"1b068d99d6e43ba9318cb12b365fd9c97d0d130eb86a631b82664c3776e8ae94","sequence_start":1,"source_sequence_checksum":"5f3c51957684d959aef27fe1997c2728","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":45,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P37173-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P37173-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P37173-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":7126,"format":"json","sha256":"0742e4351f94e3876da69cd0d5ced358fac15f8a134dd62a9a9665d28f735408","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.203,"fraction_plddt_low":0.048,"fraction_plddt_very_high":0.571,"fraction_plddt_very_low":0.178,"global_plddt":81.0,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P37173-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2006-10-17"},"source_url":"https://alphafold.ebi.ac.uk/entry/P37173","structure_class":"predicted target model","structure_id":"S-AF-P37173-F1","structure_resource_rank":85,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000163513","target_symbol":"TGFBR2","uniprot_accession":"P37173"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":799,"sequence_length":799,"sequence_sha256":"bd4f66185e4e7ba895a3613e5109f247d38e0f98da30d4eb06f6e38760074c49","sequence_start":1,"source_sequence_checksum":"834878474de602cb2110d975a8ef54e0","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":46,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P18084-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P18084-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P18084-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":3298,"format":"json","sha256":"f53555c4ef7cebc5cb26ee7ac69225b2e32808d860dd556f19e25bc88f42d4ab","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.509,"fraction_plddt_low":0.095,"fraction_plddt_very_high":0.333,"fraction_plddt_very_low":0.063,"global_plddt":82.19,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P18084-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1990-11-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/P18084","structure_class":"predicted target model","structure_id":"S-AF-P18084-F1","structure_resource_rank":88,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000082781","target_symbol":"ITGB5","uniprot_accession":"P18084"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":358,"sequence_length":358,"sequence_sha256":"c44ad4cd8d5338b0dfd0c9e1bf242e7a650b209b7af90aaf304e9f8a95f43903","sequence_start":1,"source_sequence_checksum":"5dd7befbbf124908b94e435e6489d9ba","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":47,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P13747-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P13747-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P13747-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":2452,"format":"json","sha256":"2cdf4fa08fec4307e05e039b5686572e01991f5a9bf65872af6fcfc1db24425f","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.089,"fraction_plddt_low":0.05,"fraction_plddt_very_high":0.746,"fraction_plddt_very_low":0.115,"global_plddt":87.0,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P13747-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2018-12-05"},"source_url":"https://alphafold.ebi.ac.uk/entry/P13747","structure_class":"predicted target model","structure_id":"S-AF-P13747-F1","structure_resource_rank":51,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000204592","target_symbol":"HLA-E","uniprot_accession":"P13747"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":1048,"sequence_length":1048,"sequence_sha256":"d5e1e101edb8e81ca39900444877a2dcc9e6080adffde94a47d58b0ee6f6c811","sequence_start":1,"source_sequence_checksum":"915fe32307fb678af3b3d97be8411ab5","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":{"bytes":980567,"format":"mmcif","sha256":"c467c8a3dffa28b240ce3bc46a27ac0b4cc232c8501cf1b6cd39ffa9b5b0344d","storage":"external-artifact-root"},"priority_selected":true,"retrieved_at":"2026-09-04","source_url":"https://alphafold.ebi.ac.uk/files/AF-P06756-F1-model_v6.cif","state":"reused","transport":"trusted cifUrl file download"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":48,"experimental_structure_ids":["S-RCSB-8TCG","S-RCSB-8TCG-RFD3-AB"],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P06756-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P06756-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P06756-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":10754,"format":"json","sha256":"d5a75480e1ea1207d7d33352127efdc47881f250ffcba06c2df125a73df0b57c","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.164,"fraction_plddt_low":0.028,"fraction_plddt_very_high":0.73,"fraction_plddt_very_low":0.078,"global_plddt":88.31,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P06756-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2007-04-03"},"source_url":"https://alphafold.ebi.ac.uk/entry/P06756","structure_class":"predicted target model","structure_id":"S-AF-P06756-F1","structure_resource_rank":12,"structure_tier":"structure-b","target_id":"T-ENSG00000138448","target_symbol":"ITGAV","uniprot_accession":"P06756"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":640,"sequence_length":640,"sequence_sha256":"7571b2a7d1e56afea59b7555aece78da62c51b2604261693e7ba6419f730b721","sequence_start":1,"source_sequence_checksum":"f5bd6e05385eff0ac5e1d40809b1e004","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":49,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q02297-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q02297-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q02297-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":27100,"format":"json","sha256":"4c489c7f1cdb6f160c94743c31dcdc34d92f61734750993df3512cf521d237a8","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.125,"fraction_plddt_low":0.089,"fraction_plddt_very_high":0.17,"fraction_plddt_very_low":0.616,"global_plddt":56.66,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q02297-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2007-01-23"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q02297","structure_class":"predicted target model","structure_id":"S-AF-Q02297-F1","structure_resource_rank":89,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000157168","target_symbol":"NRG1","uniprot_accession":"Q02297"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":1179,"sequence_length":1179,"sequence_sha256":"f63326baee8bee75af28ec24210c7f6907962394ad1a18e60791d30c6009cbb4","sequence_start":1,"source_sequence_checksum":"82c980f633af28138acabb5331909fcf","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":50,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P56199-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P56199-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P56199-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":4061,"format":"json","sha256":"66337c7dc10d65d0b7787c14cf1a201aebe6d462ed55058b88b147a494b1332c","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.421,"fraction_plddt_low":0.115,"fraction_plddt_very_high":0.422,"fraction_plddt_very_low":0.043,"global_plddt":83.62,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P56199-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2007-01-23"},"source_url":"https://alphafold.ebi.ac.uk/entry/P56199","structure_class":"predicted target model","structure_id":"S-AF-P56199-F1","structure_resource_rank":90,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000213949","target_symbol":"ITGA1","uniprot_accession":"P56199"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":534,"sequence_length":534,"sequence_sha256":"cfc4df123ba3da6e3b2e07252c3a396aa97265dcb448d12e36a85e241758eda5","sequence_start":1,"source_sequence_checksum":"ed478076ca9124089d82cfce028f4fbe","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":{"bytes":475316,"format":"mmcif","sha256":"57bd294c521c0c5768fe34ea7731042936b896ea6a175d8700858450bd3d4411","storage":"external-artifact-root"},"priority_selected":true,"retrieved_at":"2026-09-04","source_url":"https://alphafold.ebi.ac.uk/files/AF-Q5ZPR3-F1-model_v6.cif","state":"reused","transport":"trusted cifUrl file download"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":51,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q5ZPR3-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q5ZPR3-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q5ZPR3-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":9835,"format":"json","sha256":"25d26ecbc577d38d621cfd4de0c1734c97edc86d0230e714e1b33780f8732a1e","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.238,"fraction_plddt_low":0.067,"fraction_plddt_very_high":0.588,"fraction_plddt_very_low":0.107,"global_plddt":83.31,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q5ZPR3-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2004-11-23"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q5ZPR3","structure_class":"predicted target model","structure_id":"S-AF-Q5ZPR3-F1","structure_resource_rank":33,"structure_tier":"structure-c","target_id":"T-ENSG00000103855","target_symbol":"CD276","uniprot_accession":"Q5ZPR3"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":1456,"sequence_length":1456,"sequence_sha256":"1eafedc306dbd42607a11e44842484bc0313196bda0e25d6e55a5856e4dd210e","sequence_start":1,"source_sequence_checksum":"680191aa39fcf65fd228fe2797297906","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":52,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P22897-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P22897-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P22897-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":7098,"format":"json","sha256":"22664fb92fbd67fbe827090bc47f2524d7083be21da1fc579edfa688375db3d2","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.394,"fraction_plddt_low":0.081,"fraction_plddt_very_high":0.44,"fraction_plddt_very_low":0.084,"global_plddt":82.06,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P22897-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1991-08-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/P22897","structure_class":"predicted target model","structure_id":"S-AF-P22897-F1","structure_resource_rank":91,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000260314","target_symbol":"MRC1","uniprot_accession":"P22897"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":1306,"sequence_length":1306,"sequence_sha256":"b0ce0e4d7fe877d892127ded1065394926dfbc5f99908525083ec48b94cbec06","sequence_start":1,"source_sequence_checksum":"803ff227f325068acf025be0bfda2c27","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":53,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P08575-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P08575-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P08575-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":31794,"format":"json","sha256":"b87afd62fd5522976b6ff587b035152dd144c404d28623cdca6d3e316229ce1d","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.226,"fraction_plddt_low":0.031,"fraction_plddt_very_high":0.494,"fraction_plddt_very_low":0.249,"global_plddt":76.06,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P08575-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2018-03-28"},"source_url":"https://alphafold.ebi.ac.uk/entry/P08575","structure_class":"predicted target model","structure_id":"S-AF-P08575-F1","structure_resource_rank":92,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000081237","target_symbol":"PTPRC","uniprot_accession":"P08575"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":235,"sequence_length":235,"sequence_sha256":"ff7cd0b8004f0885dcc51de5b2a080fcc5d6888449c79ce2a57f791251041021","sequence_start":1,"source_sequence_checksum":"7e74731a8583eb61055862c16f8ddaf9","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":54,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P01732-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P01732-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P01732-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":6123,"format":"json","sha256":"bd85690f9a89a64f93aff32d98bd152908961c20743f2b7e5fcf77a6a8e86767","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.196,"fraction_plddt_low":0.187,"fraction_plddt_very_high":0.472,"fraction_plddt_very_low":0.145,"global_plddt":78.19,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P01732-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1986-07-21"},"source_url":"https://alphafold.ebi.ac.uk/entry/P01732","structure_class":"predicted target model","structure_id":"S-AF-P01732-F1","structure_resource_rank":93,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000153563","target_symbol":"CD8A","uniprot_accession":"P01732"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":323,"sequence_length":323,"sequence_sha256":"caa66c8069880514fd225b7c8673a1f4877dbfc3e15d10e69400cb453a226918","sequence_start":1,"source_sequence_checksum":"ebc0d41ccdc9d8547cd1c3ab6ac21949","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":{"bytes":296718,"format":"mmcif","sha256":"673fc076c0557d8df77029e3c9abd57f33f7f845f2418473eb74ce5fcd0f1a25","storage":"external-artifact-root"},"priority_selected":true,"retrieved_at":"2026-09-04","source_url":"https://alphafold.ebi.ac.uk/files/AF-Q08722-F1-model_v6.cif","state":"reused","transport":"trusted cifUrl file download"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":55,"experimental_structure_ids":["S-RCSB-2JJS"],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q08722-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q08722-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q08722-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":8595,"format":"json","sha256":"97d0fc9160b2ea973393ca43660a96e8a9a8ff7554b3f9ed176c5164283638db","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.183,"fraction_plddt_low":0.09,"fraction_plddt_very_high":0.663,"fraction_plddt_very_low":0.065,"global_plddt":86.31,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q08722-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1995-11-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q08722","structure_class":"predicted target model","structure_id":"S-AF-Q08722-F1","structure_resource_rank":10,"structure_tier":"structure-a","target_id":"T-ENSG00000196776","target_symbol":"CD47","uniprot_accession":"Q08722"},{"binding_evidence":false,"claim_ceiling":"no AlphaFold Database model indexed","coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"prediction-index-gap","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":56,"experimental_structure_ids":[],"failure":{"code":"network_error","message":"Request failed for alphafold-skill: HTTPError"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_state":"unavailable","source_accession":"AF-Q8WXI7-F1","source_database":"AlphaFold Protein Structure Database","source_url":"https://alphafold.ebi.ac.uk/entry/Q8WXI7","structure_class":"no suitable structure found","structure_id":"S-AFDB-Q8WXI7-F1","structure_resource_rank":94,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000181143","target_symbol":"MUC16","uniprot_accession":"Q8WXI7"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":805,"sequence_length":805,"sequence_sha256":"87630d0ccd9e8de7f77cb47c03fd56d745d66fbdceb8a2149b3518b04d71e1ea","sequence_start":1,"source_sequence_checksum":"906dc56d5c9c5513eef859ee82e80267","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":57,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q9BYF1-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q9BYF1-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q9BYF1-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":5720,"format":"json","sha256":"52eb719679184a8bf03a2779022fd90641efc8bf9f994021da93b5e2655ff7c9","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.14,"fraction_plddt_low":0.03,"fraction_plddt_very_high":0.781,"fraction_plddt_very_low":0.048,"global_plddt":90.69,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q9BYF1-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2005-08-02"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q9BYF1","structure_class":"predicted target model","structure_id":"S-AF-Q9BYF1-F1","structure_resource_rank":95,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000130234","target_symbol":"ACE2","uniprot_accession":"Q9BYF1"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":1218,"sequence_length":1218,"sequence_sha256":"9e09344716f80e5ff5d1f913ca90061a26fdaaf4f8836649f84bd66c1dbd4aa5","sequence_start":1,"source_sequence_checksum":"84706f0ee2a4d23ae4050036e62dac5d","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":58,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P78504-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P78504-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P78504-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":7717,"format":"json","sha256":"03f7ae9219c34b752b40ddba21f822ab4d08cb7f6f8c75bdbd55dff2ef7358dc","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.559,"fraction_plddt_low":0.168,"fraction_plddt_very_high":0.136,"fraction_plddt_very_low":0.136,"global_plddt":73.12,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P78504-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2002-05-02"},"source_url":"https://alphafold.ebi.ac.uk/entry/P78504","structure_class":"predicted target model","structure_id":"S-AF-P78504-F1","structure_resource_rank":96,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000101384","target_symbol":"JAG1","uniprot_accession":"P78504"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":1106,"sequence_length":1106,"sequence_sha256":"809c105e2a6e885c842e5d098845d69476d417336b2a21c12259fdcbc240cb32","sequence_start":1,"source_sequence_checksum":"364f9869f2761b926eb2723d24aa5fee","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":59,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P09619-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P09619-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P09619-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":6112,"format":"json","sha256":"29751db6fef6764954544cd49e1d76009e31745f2908fe68c5ad005cd786ea79","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.362,"fraction_plddt_low":0.112,"fraction_plddt_very_high":0.295,"fraction_plddt_very_low":0.231,"global_plddt":72.44,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P09619-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1989-07-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/P09619","structure_class":"predicted target model","structure_id":"S-AF-P09619-F1","structure_resource_rank":58,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000113721","target_symbol":"PDGFRB","uniprot_accession":"P09619"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":1089,"sequence_length":1089,"sequence_sha256":"96a4d83a02900a0cba9954d64106f1a532b0209e0d2b86d205a98bd847335682","sequence_start":1,"source_sequence_checksum":"312ca57791f95f6dc515db8edb69595a","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":60,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P16234-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P16234-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P16234-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":8825,"format":"json","sha256":"f1038c12bee57bd9196a95e2d0f258caf79f6722afdccf3198138fe31a19efbc","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.421,"fraction_plddt_low":0.125,"fraction_plddt_very_high":0.247,"fraction_plddt_very_low":0.208,"global_plddt":72.69,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P16234-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1990-04-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/P16234","structure_class":"predicted target model","structure_id":"S-AF-P16234-F1","structure_resource_rank":97,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000134853","target_symbol":"PDGFRA","uniprot_accession":"P16234"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":909,"sequence_length":909,"sequence_sha256":"696d82299defbaf3542e8fd066f5537b4fc2a2e2bad4a533b86a45e401a0b73c","sequence_start":1,"source_sequence_checksum":"9f502fa5ebcf55c7949e7b466a0578cf","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":61,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-O43184-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-O43184-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-O43184-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":12511,"format":"json","sha256":"00c290657f86e8b908fde9bf828cbaf0c901abed2031698abc154e6ecc4f772c","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.299,"fraction_plddt_low":0.089,"fraction_plddt_very_high":0.35,"fraction_plddt_very_low":0.262,"global_plddt":72.31,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-O43184-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2009-05-05"},"source_url":"https://alphafold.ebi.ac.uk/entry/O43184","structure_class":"predicted target model","structure_id":"S-AF-O43184-F1","structure_resource_rank":98,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000148848","target_symbol":"ADAM12","uniprot_accession":"O43184"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":290,"sequence_length":290,"sequence_sha256":"b1b17c7fca3cbab15bc66b90bd4c07f73617cb5a03db105b0a38084fe7bca48b","sequence_start":1,"source_sequence_checksum":"59e77826124f78fb87da94c44752feb3","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":{"bytes":280737,"format":"mmcif","sha256":"92c627e14f344407707d3410f72a97f3b0e022efc48bc89f79850fc20e03f1c9","storage":"external-artifact-root"},"priority_selected":true,"retrieved_at":"2026-09-04","source_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NZQ7-F1-model_v6.cif","state":"reused","transport":"trusted cifUrl file download"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":62,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NZQ7-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NZQ7-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NZQ7-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":7935,"format":"json","sha256":"5b384f0938687e771e1c436c212b73b1539677fdc94b3133741539bf7a755113","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.134,"fraction_plddt_low":0.138,"fraction_plddt_very_high":0.71,"fraction_plddt_very_low":0.017,"global_plddt":88.25,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q9NZQ7-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2000-10-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q9NZQ7","structure_class":"predicted target model","structure_id":"S-AF-Q9NZQ7-F1","structure_resource_rank":18,"structure_tier":"structure-b","target_id":"T-ENSG00000120217","target_symbol":"CD274","uniprot_accession":"Q9NZQ7"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":2321,"sequence_length":2321,"sequence_sha256":"de1abe5d688aabf4a87f460e9042587a2b972609f005b01d860b95e1ad1b70a1","sequence_start":1,"source_sequence_checksum":"ac9450630aed31ac1ce523dc02a04ac3","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":63,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UM47-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UM47-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UM47-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":6370,"format":"json","sha256":"840deba8644585ae08a6bff193b15881cac1b21ad6edf45d99a83d000210468e","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.333,"fraction_plddt_low":0.352,"fraction_plddt_very_high":0.065,"fraction_plddt_very_low":0.25,"global_plddt":61.44,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q9UM47-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2011-02-08"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q9UM47","structure_class":"predicted target model","structure_id":"S-AF-Q9UM47-F1","structure_resource_rank":99,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000074181","target_symbol":"NOTCH3","uniprot_accession":"Q9UM47"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":372,"sequence_length":372,"sequence_sha256":"28ea52e4a2c9c8a43fc8f2ae203a75cf1c7e0bc0aec5158bcfa6c333d613342d","sequence_start":1,"source_sequence_checksum":"8aa5687c0f3f296f5e8ca366890ddb11","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":64,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P14151-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P14151-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P14151-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":4663,"format":"json","sha256":"8709041a5fd6c03370db4d0e7a27c5488c13b2e3e224c9f11fa23adff10028e0","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.108,"fraction_plddt_low":0.094,"fraction_plddt_very_high":0.702,"fraction_plddt_very_low":0.097,"global_plddt":85.31,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P14151-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1991-02-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/P14151","structure_class":"predicted target model","structure_id":"S-AF-P14151-F1","structure_resource_rank":100,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000188404","target_symbol":"SELL","uniprot_accession":"P14151"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":976,"sequence_length":976,"sequence_sha256":"29416c9490a3c35fa69a9086f09fb7c75915d5d7467cb594e5b517e8fa9f344f","sequence_start":1,"source_sequence_checksum":"751c83ccaa7e8981affa3780720de9ec","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":{"bytes":885608,"format":"mmcif","sha256":"a9676f4b9579b9e17d8626f74dd94d651d70591c417a8f34469a77966ac20f71","storage":"external-artifact-root"},"priority_selected":true,"retrieved_at":"2026-09-04","source_url":"https://alphafold.ebi.ac.uk/files/AF-P29317-F1-model_v6.cif","state":"reused","transport":"trusted cifUrl file download"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":65,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P29317-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P29317-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P29317-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":6130,"format":"json","sha256":"69344b755d3085e4ba3500b2cbfe0e0673bb33b55fdcc92d8c5dcee8d660fab4","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.365,"fraction_plddt_low":0.077,"fraction_plddt_very_high":0.467,"fraction_plddt_very_low":0.091,"global_plddt":82.25,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P29317-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2009-05-05"},"source_url":"https://alphafold.ebi.ac.uk/entry/P29317","structure_class":"predicted target model","structure_id":"S-AF-P29317-F1","structure_resource_rank":46,"structure_tier":"structure-c","target_id":"T-ENSG00000142627","target_symbol":"EPHA2","uniprot_accession":"P29317"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":821,"sequence_length":821,"sequence_sha256":"c81b4e9e806e0ace9f779e65477e6c988dea6cad5eecfbcb35f2364c5fc884dd","sequence_start":1,"source_sequence_checksum":"8278583234a3eda2a192d8bb50e1fab8","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":66,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P21802-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P21802-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P21802-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":49540,"format":"json","sha256":"aa399e514589c00652f52e9352b3a77bbe9619f929be9148fde6c3b16aca8c17","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.306,"fraction_plddt_low":0.073,"fraction_plddt_very_high":0.367,"fraction_plddt_very_low":0.255,"global_plddt":73.94,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P21802-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1991-05-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/P21802","structure_class":"predicted target model","structure_id":"S-AF-P21802-F1","structure_resource_rank":62,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000066468","target_symbol":"FGFR2","uniprot_accession":"P21802"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":748,"sequence_length":748,"sequence_sha256":"74a4db6b2d0c653bda0ad7877139bd95207b603f7665c60adce2ef7045bb215d","sequence_start":1,"source_sequence_checksum":"584a7d9ab8e6ec6d909ef02e619d7ee8","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":{"bytes":689575,"format":"mmcif","sha256":"afe174f1234709e469e40619afff18f92d8c432c193dbeda7415bf4cd891fe0d","storage":"external-artifact-root"},"priority_selected":true,"retrieved_at":"2026-09-04","source_url":"https://alphafold.ebi.ac.uk/files/AF-O14672-F1-model_v6.cif","state":"reused","transport":"trusted cifUrl file download"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":67,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-O14672-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-O14672-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-O14672-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":5651,"format":"json","sha256":"5c3269549a254c25b35f09b89744ddd013c20236f735c3e075708693f19644cf","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.412,"fraction_plddt_low":0.116,"fraction_plddt_very_high":0.378,"fraction_plddt_very_low":0.094,"global_plddt":80.06,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-O14672-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1998-01-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/O14672","structure_class":"predicted target model","structure_id":"S-AF-O14672-F1","structure_resource_rank":40,"structure_tier":"structure-c","target_id":"T-ENSG00000137845","target_symbol":"ADAM10","uniprot_accession":"O14672"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":2347,"sequence_length":2347,"sequence_sha256":"cf559ca22e969dc6a8bb865fe5e89cf38d07e22a24caf182f8384201045496e1","sequence_start":1,"source_sequence_checksum":"69f18bd2bccdc73111154f2d23b9e30a","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":68,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P08922-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P08922-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P08922-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":6421,"format":"json","sha256":"de68d8ab6acba4852caa7eeccd730a95789f4d3c870ce0bfeef8047e2435b5fa","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.62,"fraction_plddt_low":0.169,"fraction_plddt_very_high":0.067,"fraction_plddt_very_low":0.144,"global_plddt":72.19,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P08922-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2007-02-20"},"source_url":"https://alphafold.ebi.ac.uk/entry/P08922","structure_class":"predicted target model","structure_id":"S-AF-P08922-F1","structure_resource_rank":101,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000047936","target_symbol":"ROS1","uniprot_accession":"P08922"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":1280,"sequence_length":1280,"sequence_sha256":"e104bd0942475592d1b9846250cd047178657b11a0718e3dc71de016002d13f9","sequence_start":1,"source_sequence_checksum":"e8c72a9371a2775313fe0714108c5e40","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":69,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P08183-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P08183-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P08183-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":8188,"format":"json","sha256":"38dc471e93dda085f30ab66ff61ee08904fa3246e17e4d9bac930559a3624835","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.345,"fraction_plddt_low":0.033,"fraction_plddt_very_high":0.545,"fraction_plddt_very_low":0.077,"global_plddt":84.56,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P08183-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2009-05-26"},"source_url":"https://alphafold.ebi.ac.uk/entry/P08183","structure_class":"predicted target model","structure_id":"S-AF-P08183-F1","structure_resource_rank":102,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000085563","target_symbol":"ABCB1","uniprot_accession":"P08183"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":387,"sequence_length":387,"sequence_sha256":"75372d1e810059ce73a76efa4867008a6a6a521d2e354fe5a21b375c60ac89e8","sequence_start":1,"source_sequence_checksum":"1c8b7ac47b65c2a3d8bae0473a75c36c","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":70,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q86XK7-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q86XK7-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q86XK7-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":4858,"format":"json","sha256":"5aeec54b857eeb2803aa88be4544c7b972f1ba052b3c380e3f35b1b2eacb78ee","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.158,"fraction_plddt_low":0.186,"fraction_plddt_very_high":0.444,"fraction_plddt_very_low":0.212,"global_plddt":75.62,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q86XK7-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2003-06-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q86XK7","structure_class":"predicted target model","structure_id":"S-AF-Q86XK7-F1","structure_resource_rank":103,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000101842","target_symbol":"VSIG1","uniprot_accession":"Q86XK7"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":335,"sequence_length":335,"sequence_sha256":"6ef31e1bc4afc523da622ec2732076c498b9cc99c8c3eeeeb5ef020dc9490d89","sequence_start":1,"source_sequence_checksum":"7f8380491a7e2ecdfe32f9a074263eb6","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":{"bytes":308167,"format":"mmcif","sha256":"4ab06d9ea6e08eba69124c33eddf55d95574140885603c5bffe4b3b87a7d48ce","storage":"external-artifact-root"},"priority_selected":true,"retrieved_at":"2026-09-04","source_url":"https://alphafold.ebi.ac.uk/files/AF-Q03405-F1-model_v6.cif","state":"reused","transport":"trusted cifUrl file download"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":71,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q03405-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q03405-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q03405-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":8614,"format":"json","sha256":"408ee73af4bdd6fdfb62e1c6624cda38cd6ce96fd930b49ac2b411c8d95c4b6a","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.146,"fraction_plddt_low":0.06,"fraction_plddt_very_high":0.612,"fraction_plddt_very_low":0.182,"global_plddt":81.44,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q03405-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1994-02-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q03405","structure_class":"predicted target model","structure_id":"S-AF-Q03405-F1","structure_resource_rank":24,"structure_tier":"structure-b","target_id":"T-ENSG00000011422","target_symbol":"PLAUR","uniprot_accession":"Q03405"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":738,"sequence_length":738,"sequence_sha256":"986807d8fc15aaad44bf5c74e9ceb2061075622e742b1eb27cfeca7796280138","sequence_start":1,"source_sequence_checksum":"33f2edb9c7b3098e3cc72befc2f6c36d","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":72,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P16284-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P16284-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P16284-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":17842,"format":"json","sha256":"67ae7d932a623663a70ac3b371921cf6de6b9b6c1ee73de5457b4ed418c1da92","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.232,"fraction_plddt_low":0.041,"fraction_plddt_very_high":0.558,"fraction_plddt_very_low":0.169,"global_plddt":80.44,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P16284-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2018-03-28"},"source_url":"https://alphafold.ebi.ac.uk/entry/P16284","structure_class":"predicted target model","structure_id":"S-AF-P16284-F1","structure_resource_rank":104,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000261371","target_symbol":"PECAM1","uniprot_accession":"P16284"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":976,"sequence_length":976,"sequence_sha256":"7b430dd4888d7410e8d65d331b8bd4f5bd9abd4f3a9290f2a93f37b0ed495c5c","sequence_start":1,"source_sequence_checksum":"f753f2b2d9752a30646c83e8630d1df8","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":73,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P10721-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P10721-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P10721-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":9097,"format":"json","sha256":"88a41657f81b116ade825287bf84e461fcdda61ac5bb02c0f46fe5783442385d","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.236,"fraction_plddt_low":0.102,"fraction_plddt_very_high":0.5,"fraction_plddt_very_low":0.162,"global_plddt":78.19,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P10721-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1989-07-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/P10721","structure_class":"predicted target model","structure_id":"S-AF-P10721-F1","structure_resource_rank":105,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000157404","target_symbol":"KIT","uniprot_accession":"P10721"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":865,"sequence_length":865,"sequence_sha256":"cb68350aedcd637e801a54a16f8c205c920dcde6c9f2c595bcd4a0b56251df77","sequence_start":1,"source_sequence_checksum":"4ba9752a45ab048ea5e03b9f62192938","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":74,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-O43490-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-O43490-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-O43490-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":22200,"format":"json","sha256":"e4cc5c163ebb6e08d639e09dfbb40d92b477b46ef4ae4ea50b5dacb26062d6d8","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.313,"fraction_plddt_low":0.021,"fraction_plddt_very_high":0.587,"fraction_plddt_very_low":0.079,"global_plddt":85.5,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-O43490-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1998-06-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/O43490","structure_class":"predicted target model","structure_id":"S-AF-O43490-F1","structure_resource_rank":63,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000007062","target_symbol":"PROM1","uniprot_accession":"O43490"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":442,"sequence_length":442,"sequence_sha256":"2647faacd277934cdb68d42958afebf6807a736c56550a20fff607d8e730055f","sequence_start":1,"source_sequence_checksum":"5796ad80b71069de1fd7932bd92b0778","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":75,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q9BX97-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q9BX97-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q9BX97-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":2608,"format":"json","sha256":"fd7aae354b9741ec1add5f83e09989e0b32c5b5ce2e318d336537cab07a93363","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.348,"fraction_plddt_low":0.075,"fraction_plddt_very_high":0.468,"fraction_plddt_very_low":0.109,"global_plddt":81.69,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q9BX97-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2001-06-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q9BX97","structure_class":"predicted target model","structure_id":"S-AF-Q9BX97-F1","structure_resource_rank":106,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000130300","target_symbol":"PLVAP","uniprot_accession":"Q9BX97"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":375,"sequence_length":375,"sequence_sha256":"5e99a0fa68e32001c51058e911d823bca3daec4d518d720b65ecd89e44fd7f96","sequence_start":1,"source_sequence_checksum":"1af95f3749986237561fb006bbc74da2","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":76,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q99527-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q99527-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q99527-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":2473,"format":"json","sha256":"4f440406875961cb72e74766fab6c3e3e52a1cf65e4ca7e4090b9d5d0a7b6af3","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.293,"fraction_plddt_low":0.155,"fraction_plddt_very_high":0.421,"fraction_plddt_very_low":0.131,"global_plddt":79.12,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q99527-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1997-05-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q99527","structure_class":"predicted target model","structure_id":"S-AF-Q99527-F1","structure_resource_rank":107,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000164850","target_symbol":"GPER1","uniprot_accession":"Q99527"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":119,"sequence_length":119,"sequence_sha256":"c319ce623de7d59e9e73c6daf7ec603d5e5ed48358f54b97d1eccdc3c9bf693b","sequence_start":1,"source_sequence_checksum":"67fb16dca90b73adcaefc336a6190817","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":77,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P61769-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P61769-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P61769-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":1939,"format":"json","sha256":"3f6bd18deb212b951ecabd5e8b10ad51fd9eb2fe71b1f9191d1645cf99937e5f","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.109,"fraction_plddt_low":0.059,"fraction_plddt_very_high":0.832,"fraction_plddt_very_low":0.0,"global_plddt":94.06,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P61769-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1986-07-21"},"source_url":"https://alphafold.ebi.ac.uk/entry/P61769","structure_class":"predicted target model","structure_id":"S-AF-P61769-F1","structure_resource_rank":108,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000166710","target_symbol":"B2M","uniprot_accession":"P61769"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":967,"sequence_length":967,"sequence_sha256":"3516f5207cb15271b20a091837c8200814b81e67de26a6fb9572dd4030f21631","sequence_start":1,"source_sequence_checksum":"82623163dd14001ea14d53df0ab1beaa","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":78,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q9HBX8-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q9HBX8-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q9HBX8-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":10171,"format":"json","sha256":"a1ff700d55311ef6ef36008add3cf6134a419acb545bdb7817a1a471e4f88c32","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.208,"fraction_plddt_low":0.049,"fraction_plddt_very_high":0.527,"fraction_plddt_very_low":0.216,"global_plddt":77.38,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q9HBX8-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2007-09-11"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q9HBX8","structure_class":"predicted target model","structure_id":"S-AF-Q9HBX8-F1","structure_resource_rank":109,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000133067","target_symbol":"LGR6","uniprot_accession":"Q9HBX8"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":382,"sequence_length":382,"sequence_sha256":"57ac4ca5808e70e179c865f45cbc931a716b9e7786f80621bea69292f074948e","sequence_start":1,"source_sequence_checksum":"7dd9e0f64e07843cd8b5a8545638f8c6","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":79,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P17302-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P17302-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P17302-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":2476,"format":"json","sha256":"90d797df41daa4e287bb0a1f172c9d57e6f7be1ab5cead7daab3bfc1471b131d","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.283,"fraction_plddt_low":0.113,"fraction_plddt_very_high":0.298,"fraction_plddt_very_low":0.306,"global_plddt":69.81,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P17302-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2007-01-23"},"source_url":"https://alphafold.ebi.ac.uk/entry/P17302","structure_class":"predicted target model","structure_id":"S-AF-P17302-F1","structure_resource_rank":110,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000152661","target_symbol":"GJA1","uniprot_accession":"P17302"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":458,"sequence_length":458,"sequence_sha256":"b598cecf65abf705dba5812286f09dfd6921c638b3f0c7cbee5a156df090db63","sequence_start":1,"source_sequence_checksum":"91ad571225fa48d4b2c4698eadd20e4a","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":80,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P01730-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P01730-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P01730-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":2629,"format":"json","sha256":"a4e06f2dd1a1243a85cbd43d32d334ea65c67b7716c3659b41f7e0525dd990e2","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.188,"fraction_plddt_low":0.079,"fraction_plddt_very_high":0.646,"fraction_plddt_very_low":0.087,"global_plddt":85.25,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P01730-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1988-11-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/P01730","structure_class":"predicted target model","structure_id":"S-AF-P01730-F1","structure_resource_rank":111,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000010610","target_symbol":"CD4","uniprot_accession":"P01730"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":750,"sequence_length":750,"sequence_sha256":"1a916537b7b555892eb6262b941745a4bee0eec5d0d65b73609e69a3a5ace44f","sequence_start":1,"source_sequence_checksum":"8dc8bb79c513dfe6843cb591b957a81d","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":81,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P08473-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P08473-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P08473-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":3191,"format":"json","sha256":"eda803f0ca046db3ce1452cb8992dcec5b48fad2902351b351c1a8e2deef1c8f","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.033,"fraction_plddt_low":0.012,"fraction_plddt_very_high":0.935,"fraction_plddt_very_low":0.02,"global_plddt":96.19,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P08473-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2007-01-23"},"source_url":"https://alphafold.ebi.ac.uk/entry/P08473","structure_class":"predicted target model","structure_id":"S-AF-P08473-F1","structure_resource_rank":112,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000196549","target_symbol":"MME","uniprot_accession":"P08473"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":277,"sequence_length":277,"sequence_sha256":"961acc71fe9b1ba77818a9ff4ffc482d025282f51ac07b592ad4ddeadfc2d60e","sequence_start":1,"source_sequence_checksum":"079dd1d204def55e61ca01fa0fd014f1","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":82,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P43489-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P43489-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P43489-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":2291,"format":"json","sha256":"45827e96124a5640ca3d02e80407140b2d1b99bde688a717f0cd018e75603c61","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.072,"fraction_plddt_low":0.206,"fraction_plddt_very_high":0.513,"fraction_plddt_very_low":0.209,"global_plddt":77.0,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P43489-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1995-11-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/P43489","structure_class":"predicted target model","structure_id":"S-AF-P43489-F1","structure_resource_rank":113,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000186827","target_symbol":"TNFRSF4","uniprot_accession":"P43489"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":582,"sequence_length":582,"sequence_sha256":"5f83c7ecb5c2eb7ffdf8d83f1de9543d8039381909ba6a87fdca0898eb47e260","sequence_start":1,"source_sequence_checksum":"4d7824ddaaa164b7e53fa388b6e606d9","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":{"bytes":546988,"format":"mmcif","sha256":"175071124149710816bef59847708552b84c1bcb0746993ac38083cac73a7583","storage":"external-artifact-root"},"priority_selected":true,"retrieved_at":"2026-09-04","source_url":"https://alphafold.ebi.ac.uk/files/AF-P50281-F1-model_v6.cif","state":"reused","transport":"trusted cifUrl file download"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":83,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P50281-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P50281-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P50281-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":2876,"format":"json","sha256":"2737b010aaf1b145bf88bc4ff56613d32927083c67fc9e7c68784dc765d52c63","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.201,"fraction_plddt_low":0.062,"fraction_plddt_very_high":0.557,"fraction_plddt_very_low":0.18,"global_plddt":80.75,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P50281-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2011-01-11"},"source_url":"https://alphafold.ebi.ac.uk/entry/P50281","structure_class":"predicted target model","structure_id":"S-AF-P50281-F1","structure_resource_rank":42,"structure_tier":"structure-c","target_id":"T-ENSG00000157227","target_symbol":"MMP14","uniprot_accession":"P50281"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":556,"sequence_length":556,"sequence_sha256":"955c8406920379b400b21284c1ef1af93f34653cb8cc11fdf61e3aa84ef2b15e","sequence_start":1,"source_sequence_checksum":"4760bdfdd4c662f0739aa06390ead4aa","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":84,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P15391-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P15391-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P15391-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":5404,"format":"json","sha256":"9485ba95b8e2c8106d9f9f11c1fe55873fa8f2442507e358c864e7970f667fe1","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.192,"fraction_plddt_low":0.121,"fraction_plddt_very_high":0.239,"fraction_plddt_very_low":0.448,"global_plddt":62.22,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P15391-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2007-11-13"},"source_url":"https://alphafold.ebi.ac.uk/entry/P15391","structure_class":"predicted target model","structure_id":"S-AF-P15391-F1","structure_resource_rank":114,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000177455","target_symbol":"CD19","uniprot_accession":"P15391"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":1356,"sequence_length":1356,"sequence_sha256":"fc7e217443f8e66fc4af3971109e40c570f998fb293d1bf4f799cffcc127e76b","sequence_start":1,"source_sequence_checksum":"3b93a11bc1683dc849a09618fb5af54b","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":{"bytes":1280240,"format":"mmcif","sha256":"c915d5ab49bb3a3378ec4873222761ade9c43372998bebab999814267e7c9bc4","storage":"external-artifact-root"},"priority_selected":true,"retrieved_at":"2026-09-04","source_url":"https://alphafold.ebi.ac.uk/files/AF-P35968-F1-model_v6.cif","state":"reused","transport":"trusted cifUrl file download"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":85,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P35968-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P35968-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P35968-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":10205,"format":"json","sha256":"586e37b44245298b72245177d9816c6bca34ff178ddbfdfa87cf5a0710dda9ac","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.434,"fraction_plddt_low":0.076,"fraction_plddt_very_high":0.235,"fraction_plddt_very_low":0.255,"global_plddt":71.12,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P35968-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2000-12-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/P35968","structure_class":"predicted target model","structure_id":"S-AF-P35968-F1","structure_resource_rank":21,"structure_tier":"structure-b","target_id":"T-ENSG00000128052","target_symbol":"KDR","uniprot_accession":"P35968"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":2322,"sequence_length":2322,"sequence_sha256":"b3e4372d480afb946499f545fe67d1f4c532736435265b6ab9352ed469cf2860","sequence_start":1,"source_sequence_checksum":"0a06c8b4afd18f0d460cac8fbecd3eae","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":86,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q6UVK1-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q6UVK1-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q6UVK1-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":6366,"format":"json","sha256":"5174d2293159800aa7539bb9c5154cf06f46c7cd8f311a4da09637a8f272aa3b","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.698,"fraction_plddt_low":0.152,"fraction_plddt_very_high":0.059,"fraction_plddt_very_low":0.092,"global_plddt":74.75,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q6UVK1-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2010-05-18"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q6UVK1","structure_class":"predicted target model","structure_id":"S-AF-Q6UVK1-F1","structure_resource_rank":115,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000173546","target_symbol":"CSPG4","uniprot_accession":"Q6UVK1"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":923,"sequence_length":923,"sequence_sha256":"1d2551ade453a33a915755fda9144bb4924af48001cae8fe701fa2663318092c","sequence_start":1,"source_sequence_checksum":"77be6e1314c21f4b98b42504d4d3da2c","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":87,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-O14786-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-O14786-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-O14786-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":8966,"format":"json","sha256":"e56d5de8fa42812be3b4283727d67b4ec5c2de964193b81b875ff7c4a4969ccb","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.315,"fraction_plddt_low":0.057,"fraction_plddt_very_high":0.453,"fraction_plddt_very_low":0.174,"global_plddt":79.12,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-O14786-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2008-09-23"},"source_url":"https://alphafold.ebi.ac.uk/entry/O14786","structure_class":"predicted target model","structure_id":"S-AF-O14786-F1","structure_resource_rank":116,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000099250","target_symbol":"NRP1","uniprot_accession":"O14786"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":164,"sequence_length":164,"sequence_sha256":"72c57ad5dc4fd20675ae1e7ccfbc720ac243d369629ff5a76a21ac7166f19c9d","sequence_start":1,"source_sequence_checksum":"cf939aa91b376233ce70ab014ee9fe21","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":88,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P20963-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P20963-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P20963-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":3867,"format":"json","sha256":"5b6564f9e908650f1e17656ca5cccf837eef8546b493f91a51d3af3877013856","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.159,"fraction_plddt_low":0.585,"fraction_plddt_very_high":0.091,"fraction_plddt_very_low":0.165,"global_plddt":62.41,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P20963-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2002-10-10"},"source_url":"https://alphafold.ebi.ac.uk/entry/P20963","structure_class":"predicted target model","structure_id":"S-AF-P20963-F1","structure_resource_rank":117,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000198821","target_symbol":"CD247","uniprot_accession":"P20963"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":489,"sequence_length":489,"sequence_sha256":"137799e546b8a031745941da4798a83fdc4ddd0d0caed7bdd9a2e36468e72ce5","sequence_start":1,"source_sequence_checksum":"96c927d81f694f6b47cb3cb02160b7d0","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":89,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P58335-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P58335-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P58335-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":9498,"format":"json","sha256":"7b74debcb01bc6825a805e0802795ad66a95842c834568c8e133295ae2100aef","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.319,"fraction_plddt_low":0.247,"fraction_plddt_very_high":0.252,"fraction_plddt_very_low":0.182,"global_plddt":71.81,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P58335-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2010-10-05"},"source_url":"https://alphafold.ebi.ac.uk/entry/P58335","structure_class":"predicted target model","structure_id":"S-AF-P58335-F1","structure_resource_rank":118,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000163297","target_symbol":"ANTXR2","uniprot_accession":"P58335"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":822,"sequence_length":822,"sequence_sha256":"ef0ddbb0badae4eac53608fa57cf54c55cb837d4929048fa6a2339bb30ae8f03","sequence_start":1,"source_sequence_checksum":"79e75a9c5077e2c19f2faee1bf7e88fb","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":90,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P11362-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P11362-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P11362-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":56961,"format":"json","sha256":"1cec93a81a45054999f7b32617be8155bc74a6f2c90770f8c45dd2ffa8830054","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.363,"fraction_plddt_low":0.069,"fraction_plddt_very_high":0.335,"fraction_plddt_very_low":0.234,"global_plddt":73.88,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P11362-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1991-05-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/P11362","structure_class":"predicted target model","structure_id":"S-AF-P11362-F1","structure_resource_rank":119,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000077782","target_symbol":"FGFR1","uniprot_accession":"P11362"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":385,"sequence_length":385,"sequence_sha256":"ed79decd0ebecf11db88814fefce77dd70f004d2ae0bb732e76e6bb59cba05b3","sequence_start":1,"source_sequence_checksum":"e07b6b281e20986128c806472ef66ed8","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":91,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P28906-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P28906-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P28906-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":4642,"format":"json","sha256":"d7182e47f3c2802e3a2d481e05aa27b6b272d64a20950d7e6406c4e6506de18e","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.065,"fraction_plddt_low":0.169,"fraction_plddt_very_high":0.275,"fraction_plddt_very_low":0.491,"global_plddt":60.41,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P28906-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1998-07-15"},"source_url":"https://alphafold.ebi.ac.uk/entry/P28906","structure_class":"predicted target model","structure_id":"S-AF-P28906-F1","structure_resource_rank":120,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000174059","target_symbol":"CD34","uniprot_accession":"P28906"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":384,"sequence_length":384,"sequence_sha256":"65221c4df869b7962744a9424e56af2329253da769121e160384ea87f7d59624","sequence_start":1,"source_sequence_checksum":"a08f4253cb23248538d9365e90cd8437","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":92,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P30550-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P30550-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P30550-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":2485,"format":"json","sha256":"ebf5c753ca0c94051a986ad3208ea6cca4a345288cf57cc4a7efd4443a05f18d","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.224,"fraction_plddt_low":0.042,"fraction_plddt_very_high":0.526,"fraction_plddt_very_low":0.208,"global_plddt":78.5,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P30550-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1993-04-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/P30550","structure_class":"predicted target model","structure_id":"S-AF-P30550-F1","structure_resource_rank":52,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000126010","target_symbol":"GRPR","uniprot_accession":"P30550"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":858,"sequence_length":858,"sequence_sha256":"1e6a17513bc245221c67313254cf83721a750652613850555cfc0c1a729c79fa","sequence_start":1,"source_sequence_checksum":"c6c055e39592185899a180d086bb8abc","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":{"bytes":780890,"format":"mmcif","sha256":"9a4619db6ac26b5d766894368615289a6edfe42fef8fa3cfc66809b6d1c6b431","storage":"external-artifact-root"},"priority_selected":true,"retrieved_at":"2026-09-04","source_url":"https://alphafold.ebi.ac.uk/files/AF-P13591-F1-model_v6.cif","state":"reused","transport":"trusted cifUrl file download"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":93,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P13591-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P13591-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P13591-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":17545,"format":"json","sha256":"7d17abc83cc38fa0ff02c830297b53c4adb53ed4262bdbd56c992fbc50d9b05b","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.255,"fraction_plddt_low":0.042,"fraction_plddt_very_high":0.535,"fraction_plddt_very_low":0.168,"global_plddt":79.5,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P13591-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2008-07-22"},"source_url":"https://alphafold.ebi.ac.uk/entry/P13591","structure_class":"predicted target model","structure_id":"S-AF-P13591-F1","structure_resource_rank":30,"structure_tier":"structure-b","target_id":"T-ENSG00000149294","target_symbol":"NCAM1","uniprot_accession":"P13591"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":937,"sequence_length":937,"sequence_sha256":"ec6867bc5bacc933a118937a895d4f6d05381eab1f38a3f45a0f957b1f60ec69","sequence_start":1,"source_sequence_checksum":"d6d69c72076502751a8ea62887f1a366","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":94,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q01973-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q01973-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q01973-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":8186,"format":"json","sha256":"69d3a5d541388c8fa10f4dc8c85fd6c9fcf0d162b1a3c14419234e01d63f886e","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.344,"fraction_plddt_low":0.09,"fraction_plddt_very_high":0.249,"fraction_plddt_very_low":0.318,"global_plddt":68.19,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q01973-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2006-11-28"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q01973","structure_class":"predicted target model","structure_id":"S-AF-Q01973-F1","structure_resource_rank":121,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000185483","target_symbol":"ROR1","uniprot_accession":"Q01973"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":420,"sequence_length":420,"sequence_sha256":"51681f2cee5b5729bdc190698020665dfc2e9e327a0f5ada6907865092d8e114","sequence_start":1,"source_sequence_checksum":"183bc764c4c18bada9cada35f7cf7db4","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":{"bytes":385003,"format":"mmcif","sha256":"2c429b262dbff035482bf78e0e43696437a48b33838b6ea4bdb7285ec7b70cd0","storage":"external-artifact-root"},"priority_selected":true,"retrieved_at":"2026-09-04","source_url":"https://alphafold.ebi.ac.uk/files/AF-Q13641-F1-model_v6.cif","state":"reused","transport":"trusted cifUrl file download"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":95,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q13641-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q13641-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q13641-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":2547,"format":"json","sha256":"a8440c268ae231246c7927e1048d71b3a68be0a8a0c5608e03af6d16040d0343","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.195,"fraction_plddt_low":0.088,"fraction_plddt_very_high":0.576,"fraction_plddt_very_low":0.14,"global_plddt":82.19,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q13641-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1996-11-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q13641","structure_class":"predicted target model","structure_id":"S-AF-Q13641-F1","structure_resource_rank":38,"structure_tier":"structure-c","target_id":"T-ENSG00000146242","target_symbol":"TPBG","uniprot_accession":"Q13641"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":987,"sequence_length":987,"sequence_sha256":"37003eca217f6b25fc4ae29a2d6ffc1e7b18df0a7f2e9f9ea509a636a68f8260","sequence_start":1,"source_sequence_checksum":"861c0e725f3985dfafb5e602f3449b03","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":96,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P54760-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P54760-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P54760-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":10562,"format":"json","sha256":"591ef2654e84f2625a12fbae781b40f7a4287e8d69fbd1eab5ba33862986ca75","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.37,"fraction_plddt_low":0.071,"fraction_plddt_very_high":0.458,"fraction_plddt_very_low":0.101,"global_plddt":82.0,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P54760-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2001-10-18"},"source_url":"https://alphafold.ebi.ac.uk/entry/P54760","structure_class":"predicted target model","structure_id":"S-AF-P54760-F1","structure_resource_rank":55,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000196411","target_symbol":"EPHB4","uniprot_accession":"P54760"},{"binding_evidence":false,"claim_ceiling":"no AlphaFold Database model indexed","coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"prediction-index-gap","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":97,"experimental_structure_ids":[],"failure":{"code":"accession-model-mismatch","message":"AFDB returned no monomer prediction matching Q99102; returned models: AF-Q99102-12-F1, AF-Q99102-13-F1"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":7532,"format":"json","sha256":"e6bdcfcbba53e92f3c9bd3202534e3438f035a48c078d7ba439dacd59b0f4fd3","storage":"external-artifact-root"},"metadata_state":"unavailable","source_accession":"AF-Q99102-F1","source_database":"AlphaFold Protein Structure Database","source_url":"https://alphafold.ebi.ac.uk/entry/Q99102","structure_class":"no suitable structure found","structure_id":"S-AFDB-Q99102-F1","structure_resource_rank":122,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000145113","target_symbol":"MUC4","uniprot_accession":"Q99102"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":288,"sequence_length":288,"sequence_sha256":"c0f5745899a44e73098e606f4e09050e0b63f9b4f00cab49981806296b53d591","sequence_start":1,"source_sequence_checksum":"9d3bad62b9c482f023605c4836d94d8f","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":{"bytes":271055,"format":"mmcif","sha256":"9fc044e5aee3c92fceddf533df8b0ae85b9955d7a98cf9e277121a8c8855c17d","storage":"external-artifact-root"},"priority_selected":true,"retrieved_at":"2026-09-04","source_url":"https://alphafold.ebi.ac.uk/files/AF-Q15116-F1-model_v6.cif","state":"reused","transport":"trusted cifUrl file download"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":98,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q15116-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q15116-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q15116-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":2293,"format":"json","sha256":"b8dd5a1c3e77613edb416901d699307c61e466d2813fa43aa7d22648d3250f6e","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.212,"fraction_plddt_low":0.267,"fraction_plddt_very_high":0.358,"fraction_plddt_very_low":0.163,"global_plddt":74.12,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q15116-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2007-04-17"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q15116","structure_class":"predicted target model","structure_id":"S-AF-Q15116-F1","structure_resource_rank":15,"structure_tier":"structure-b","target_id":"T-ENSG00000188389","target_symbol":"PDCD1","uniprot_accession":"Q15116"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":655,"sequence_length":655,"sequence_sha256":"30326c2220d9e1ae10af82deb915b0251b33cdf56035a050ece15cd2fedfb894","sequence_start":1,"source_sequence_checksum":"963ffc66603f78d05e08926842e1d4ce","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":99,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UNQ0-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UNQ0-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UNQ0-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":5799,"format":"json","sha256":"2f97b3be11af204faba2031a46b120b6bf23607fcb7f10866849bac8b756a382","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.211,"fraction_plddt_low":0.047,"fraction_plddt_very_high":0.646,"fraction_plddt_very_low":0.096,"global_plddt":85.25,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q9UNQ0-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2005-05-10"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q9UNQ0","structure_class":"predicted target model","structure_id":"S-AF-Q9UNQ0-F1","structure_resource_rank":123,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000118777","target_symbol":"ABCG2","uniprot_accession":"Q9UNQ0"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":933,"sequence_length":933,"sequence_sha256":"e8316f260f3fa1cd475aa83846d041ba6f3541efd51176f4ddd70340d38bd074","sequence_start":1,"source_sequence_checksum":"49ce876c241ed28a6525884cd928886e","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":100,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q6IWH7-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q6IWH7-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q6IWH7-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":8592,"format":"json","sha256":"b49c4018f61ffff797bc800a4751e0ee24c3ba7eea91b69af2dbfd54d8af3257","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.428,"fraction_plddt_low":0.051,"fraction_plddt_very_high":0.363,"fraction_plddt_very_low":0.158,"global_plddt":77.69,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q6IWH7-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2011-05-31"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q6IWH7","structure_class":"predicted target model","structure_id":"S-AF-Q6IWH7-F1","structure_resource_rank":124,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000146205","target_symbol":"ANO7","uniprot_accession":"Q6IWH7"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":829,"sequence_length":829,"sequence_sha256":"2469935445ed65fca853e5f1237c7280a339fe2cc5d90f6b0f1ca319d21dff48","sequence_start":1,"source_sequence_checksum":"413e22a0ff79335668459321ce8ffa4a","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":101,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P22223-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P22223-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P22223-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":6374,"format":"json","sha256":"40b9f4fa3f01a10557612e583bae27ed24c63f63a7e067c906129831ec58a675","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.247,"fraction_plddt_low":0.076,"fraction_plddt_very_high":0.457,"fraction_plddt_very_low":0.22,"global_plddt":76.75,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P22223-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2007-05-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/P22223","structure_class":"predicted target model","structure_id":"S-AF-P22223-F1","structure_resource_rank":125,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000062038","target_symbol":"CDH3","uniprot_accession":"P22223"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":261,"sequence_length":261,"sequence_sha256":"89c388e151022937dd56f7be9599e2f03f07e579e7c1308d4112f0c386b1491c","sequence_start":1,"source_sequence_checksum":"7e47452b72b6b8269b13c7faa9930c7d","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":{"bytes":235865,"format":"mmcif","sha256":"7d90816425ed73e53e042ed3bfa4f2ae3912ea70c8314fd78bcff16eedbf4406","storage":"external-artifact-root"},"priority_selected":true,"retrieved_at":"2026-09-04","source_url":"https://alphafold.ebi.ac.uk/files/AF-P56856-F1-model_v6.cif","state":"reused","transport":"trusted cifUrl file download"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":102,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P56856-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P56856-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P56856-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":4197,"format":"json","sha256":"fb8a96b9e46008b665ddb1166aaf45314aeb847df7bfc131dfd0a27aab4b8df4","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.28,"fraction_plddt_low":0.199,"fraction_plddt_very_high":0.314,"fraction_plddt_very_low":0.207,"global_plddt":72.81,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P56856-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2000-05-30"},"source_url":"https://alphafold.ebi.ac.uk/entry/P56856","structure_class":"predicted target model","structure_id":"S-AF-P56856-F1","structure_resource_rank":32,"structure_tier":"structure-c","target_id":"T-ENSG00000066405","target_symbol":"CLDN18","uniprot_accession":"P56856"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":766,"sequence_length":766,"sequence_sha256":"272729ea12e07654f922db22308673539882764491f0b55e31767ec1f714c328","sequence_start":1,"source_sequence_checksum":"d6769d94cbcd9fcb5b0fbc60e0a109ea","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":103,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P27487-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P27487-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P27487-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":3236,"format":"json","sha256":"1129a15e78fa472f1dee269b21a796a6b0790248c2070a887a2112889240082b","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.038,"fraction_plddt_low":0.02,"fraction_plddt_very_high":0.932,"fraction_plddt_very_low":0.01,"global_plddt":96.25,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P27487-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1996-02-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/P27487","structure_class":"predicted target model","structure_id":"S-AF-P27487-F1","structure_resource_rank":126,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000197635","target_symbol":"DPP4","uniprot_accession":"P27487"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":361,"sequence_length":361,"sequence_sha256":"b61c11011f05f674924fd36208448ef5cb1b06449508241cff49916b813ecf0b","sequence_start":1,"source_sequence_checksum":"2f746cf9dd79d210347d05395599d410","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":104,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P21217-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P21217-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P21217-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":2473,"format":"json","sha256":"58e92cac1f04f358b6996e3a213fcbb5c7e14cd38e257a4394d3a5d13f1e7fe7","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.08,"fraction_plddt_low":0.042,"fraction_plddt_very_high":0.803,"fraction_plddt_very_low":0.075,"global_plddt":89.62,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P21217-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2024-01-24"},"source_url":"https://alphafold.ebi.ac.uk/entry/P21217","structure_class":"predicted target model","structure_id":"S-AF-P21217-F1","structure_resource_rank":127,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000171124","target_symbol":"FUT3","uniprot_accession":"P21217"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":334,"sequence_length":334,"sequence_sha256":"b8ba9acf2458ef97435d600036ced98e3e26853ce1255c0a90f25885c2804707","sequence_start":1,"source_sequence_checksum":"730f4e02f87334f9ff9754580d2a395e","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":105,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P47775-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P47775-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P47775-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":2383,"format":"json","sha256":"f43d2beffce5b7e1beaed685ea6af2578c619aac3cf89cfd41d48fe3940c223f","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.228,"fraction_plddt_low":0.066,"fraction_plddt_very_high":0.602,"fraction_plddt_very_low":0.105,"global_plddt":84.25,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P47775-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1996-02-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/P47775","structure_class":"predicted target model","structure_id":"S-AF-P47775-F1","structure_resource_rank":128,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000132975","target_symbol":"GPR12","uniprot_accession":"P47775"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":1464,"sequence_length":1464,"sequence_sha256":"1e865dd08ec23cfb4ba716c63359e383fb948aa26261eeb5a0f9d7462536db0f","sequence_start":1,"source_sequence_checksum":"4963f511fb2ad2d0a993fa102071a76c","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":106,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q12879-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q12879-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q12879-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":8702,"format":"json","sha256":"e51b4283ab2f6d20cfa0920f5c738cb14313d0646adc88f4836dfaa0a61967a6","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.293,"fraction_plddt_low":0.086,"fraction_plddt_very_high":0.188,"fraction_plddt_very_low":0.433,"global_plddt":60.84,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q12879-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1996-11-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q12879","structure_class":"predicted target model","structure_id":"S-AF-Q12879-F1","structure_resource_rank":129,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000183454","target_symbol":"GRIN2A","uniprot_accession":"Q12879"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":1367,"sequence_length":1367,"sequence_sha256":"e11a8ca0d0d551f3fa704c31f4d0af57361c9d19d838a54bdd6b63528cbb7a1e","sequence_start":1,"source_sequence_checksum":"7319b21e0d5b3e8342fa71c29192f156","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":{"bytes":1306855,"format":"mmcif","sha256":"74b0ff89d68c526a867a57b554407515ed6d675eb717a5316c4b250cbcf6fe36","storage":"external-artifact-root"},"priority_selected":true,"retrieved_at":"2026-09-04","source_url":"https://alphafold.ebi.ac.uk/files/AF-P08069-F1-model_v6.cif","state":"reused","transport":"trusted cifUrl file download"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":107,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P08069-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P08069-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P08069-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":4458,"format":"json","sha256":"c9483d22f1029e29c2901aaeeab4914690ae43c93aaf07df6ce5a769c76c5d19","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.316,"fraction_plddt_low":0.091,"fraction_plddt_very_high":0.436,"fraction_plddt_very_low":0.157,"global_plddt":78.0,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P08069-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1988-08-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/P08069","structure_class":"predicted target model","structure_id":"S-AF-P08069-F1","structure_resource_rank":27,"structure_tier":"structure-b","target_id":"T-ENSG00000140443","target_symbol":"IGF1R","uniprot_accession":"P08069"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":1188,"sequence_length":1188,"sequence_sha256":"e8992466bd05db4d22f38b0e4603add62e0fd5340d914be4d0397675ce981333","sequence_start":1,"source_sequence_checksum":"ae362cb246b4a7a8d778a459257b6420","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":108,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UKX5-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UKX5-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UKX5-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":7930,"format":"json","sha256":"244562516967e51bbd9685ce9fd36bb44bbe718ba0addff1c20f325ad88e5b50","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.412,"fraction_plddt_low":0.064,"fraction_plddt_very_high":0.481,"fraction_plddt_very_low":0.043,"global_plddt":85.38,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q9UKX5-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2010-11-30"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q9UKX5","structure_class":"predicted target model","structure_id":"S-AF-Q9UKX5-F1","structure_resource_rank":130,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000137809","target_symbol":"ITGA11","uniprot_accession":"Q9UKX5"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":1035,"sequence_length":1035,"sequence_sha256":"81527b5b53a6b5dff0e20d6edc5983c529a0ad0390a4a7a453d467d88c886c6e","sequence_start":1,"source_sequence_checksum":"1a15cc14831cb1a0ef9c2e732a4bf58e","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":109,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q13797-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q13797-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q13797-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":3772,"format":"json","sha256":"1aaeed6e13e37ad5c1f87c50e5d3a25587bcc97ba988e495ac8b4560d5f9a21a","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.376,"fraction_plddt_low":0.083,"fraction_plddt_very_high":0.501,"fraction_plddt_very_low":0.04,"global_plddt":85.06,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q13797-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2009-05-05"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q13797","structure_class":"predicted target model","structure_id":"S-AF-Q13797-F1","structure_resource_rank":131,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000144668","target_symbol":"ITGA9","uniprot_accession":"Q13797"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":788,"sequence_length":788,"sequence_sha256":"dd1f27b57d8ba531160f0b9e03b9ae50533fbe1b3205765e545b0daa3c82bb52","sequence_start":1,"source_sequence_checksum":"e3bf58cfa4245d3c4fb974a14d27d975","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":110,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P05106-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P05106-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P05106-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":9323,"format":"json","sha256":"e1ca350475439733b1ddd54719f7a8aa4badf2b2351016123b73c2e37c9dd5a7","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.294,"fraction_plddt_low":0.063,"fraction_plddt_very_high":0.6,"fraction_plddt_very_low":0.042,"global_plddt":87.0,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P05106-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2007-02-06"},"source_url":"https://alphafold.ebi.ac.uk/entry/P05106","structure_class":"predicted target model","structure_id":"S-AF-P05106-F1","structure_resource_rank":132,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000259207","target_symbol":"ITGB3","uniprot_accession":"P05106"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":907,"sequence_length":907,"sequence_sha256":"cc3dde6315d01a901a70da9905ad6066dbe3581d2a9c572151cc72773b62f0be","sequence_start":1,"source_sequence_checksum":"1f26ecfcf087318bbfdaaa239c78441a","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":{"bytes":816722,"format":"mmcif","sha256":"eefae6be3e19cbe4b3644c3d058ee4cd920c870e097f9e9b9449c2ae822eefd7","storage":"external-artifact-root"},"priority_selected":true,"retrieved_at":"2026-09-04","source_url":"https://alphafold.ebi.ac.uk/files/AF-O75473-F1-model_v6.cif","state":"reused","transport":"trusted cifUrl file download"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":111,"experimental_structure_ids":["S-RCSB-4BSU"],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-O75473-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-O75473-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-O75473-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":10000,"format":"json","sha256":"f875a1d61e87be687dc2911ebdba6e7ff89a9f68245efe8c9c00853dbbf3ed33","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.198,"fraction_plddt_low":0.051,"fraction_plddt_very_high":0.577,"fraction_plddt_very_low":0.174,"global_plddt":80.25,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-O75473-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1998-11-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/O75473","structure_class":"predicted target model","structure_id":"S-AF-O75473-F1","structure_resource_rank":13,"structure_tier":"structure-b","target_id":"T-ENSG00000139292","target_symbol":"LGR5","uniprot_accession":"O75473"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":640,"sequence_length":640,"sequence_sha256":"aa2275ada024fd3f4a739403929e6b516734aa126ba14a85fc845765b7852b49","sequence_start":1,"source_sequence_checksum":"f0ce0687218e1a7eed90648587381a2d","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":112,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q9HCJ2-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q9HCJ2-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q9HCJ2-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":3007,"format":"json","sha256":"09046c24d04fd39fd3bd13a3fd21a861da5e27cdd96dabe388ddd84cdec52f87","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.136,"fraction_plddt_low":0.052,"fraction_plddt_very_high":0.542,"fraction_plddt_very_low":0.27,"global_plddt":75.81,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q9HCJ2-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2001-03-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q9HCJ2","structure_class":"predicted target model","structure_id":"S-AF-Q9HCJ2-F1","structure_resource_rank":133,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000148948","target_symbol":"LRRC4C","uniprot_accession":"Q9HCJ2"},{"binding_evidence":false,"claim_ceiling":"no AlphaFold Database model indexed","coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"prediction-index-gap","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":113,"experimental_structure_ids":[],"failure":{"code":"network_error","message":"Request failed for alphafold-skill: HTTPError"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_state":"unavailable","source_accession":"AF-Q685J3-F1","source_database":"AlphaFold Protein Structure Database","source_url":"https://alphafold.ebi.ac.uk/entry/Q685J3","structure_class":"no suitable structure found","structure_id":"S-AFDB-Q685J3-F1","structure_resource_rank":70,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000169876","target_symbol":"MUC17","uniprot_accession":"Q685J3"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":1461,"sequence_length":1461,"sequence_sha256":"31ffd53565f7f105c5ca3c05626d40ec7b6edaffda66472664ca1b9d48b836e9","sequence_start":1,"source_sequence_checksum":"d443ec58badaed227a18fc6281e805b0","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":114,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q92859-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q92859-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q92859-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":17508,"format":"json","sha256":"07da16790bfdad02c22214eb8e55341205896d71dbd254aec07d6ca331b920e1","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.394,"fraction_plddt_low":0.084,"fraction_plddt_very_high":0.233,"fraction_plddt_very_low":0.289,"global_plddt":68.0,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q92859-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2006-10-17"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q92859","structure_class":"predicted target model","structure_id":"S-AF-Q92859-F1","structure_resource_rank":134,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000067141","target_symbol":"NEO1","uniprot_accession":"Q92859"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":427,"sequence_length":427,"sequence_sha256":"6ef5b18bd18a89c0240ac8302a4ba5764ebd628e2b740820c561e855a67443b8","sequence_start":1,"source_sequence_checksum":"301683fe929259c5e1785d1e59fa1f43","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":115,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P08138-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P08138-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P08138-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":4752,"format":"json","sha256":"31a2cc36d3938cd9f6b5f4c0be118695fe6f0c8bb5012be14e632631fc71876b","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.194,"fraction_plddt_low":0.112,"fraction_plddt_very_high":0.45,"fraction_plddt_very_low":0.244,"global_plddt":75.88,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P08138-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1988-08-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/P08138","structure_class":"predicted target model","structure_id":"S-AF-P08138-F1","structure_resource_rank":135,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000064300","target_symbol":"NGFR","uniprot_accession":"P08138"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":1827,"sequence_length":1827,"sequence_sha256":"a25a2d550fb24f94ae1d63d6e2efe97f14244a277dbfbd392b7bfeaf928c1048","sequence_start":1,"source_sequence_checksum":"7e38483ca6fe8efdd5a82a9925b69962","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":116,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P14410-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P14410-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P14410-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":5368,"format":"json","sha256":"a436b45c77d6e952f13e5347c21a6ae17a10d536844ed7745cbb2be445ae25c9","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.124,"fraction_plddt_low":0.012,"fraction_plddt_very_high":0.848,"fraction_plddt_very_low":0.016,"global_plddt":93.56,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P14410-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2011-01-11"},"source_url":"https://alphafold.ebi.ac.uk/entry/P14410","structure_class":"predicted target model","structure_id":"S-AF-P14410-F1","structure_resource_rank":136,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000090402","target_symbol":"SI","uniprot_accession":"P14410"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":406,"sequence_length":406,"sequence_sha256":"5edf4d89a116167cddf8becfae7b9a4ca6897ebe5b11fe5224a2565003f77d53","sequence_start":1,"source_sequence_checksum":"a55912aa23929f7785530d84a246965e","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":117,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q08AI6-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q08AI6-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q08AI6-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":4832,"format":"json","sha256":"0a6c128867b399ee4f2be27bff11dd621693c4c432c2bff6c69cadeb16d58a94","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.175,"fraction_plddt_low":0.015,"fraction_plddt_very_high":0.749,"fraction_plddt_very_low":0.062,"global_plddt":88.56,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q08AI6-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2006-10-31"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q08AI6","structure_class":"predicted target model","structure_id":"S-AF-Q08AI6-F1","structure_resource_rank":137,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000169507","target_symbol":"SLC38A11","uniprot_accession":"Q08AI6"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":875,"sequence_length":875,"sequence_sha256":"db40369468aab8eac858dd9c9190a36d1385c5c99c5a93d6dadf9b2ad85478d3","sequence_start":1,"source_sequence_checksum":"92febab1d9cdcc3ac6575f1a82886110","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":118,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q8NBS3-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q8NBS3-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q8NBS3-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":15548,"format":"json","sha256":"cabad99dc6865081f578d7d3826a706bfb57e7e17e6489eead2f114cf513d7d8","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.504,"fraction_plddt_low":0.107,"fraction_plddt_very_high":0.205,"fraction_plddt_very_low":0.184,"global_plddt":74.0,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q8NBS3-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2021-09-29"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q8NBS3","structure_class":"predicted target model","structure_id":"S-AF-Q8NBS3-F1","structure_resource_rank":138,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000088836","target_symbol":"SLC4A11","uniprot_accession":"Q8NBS3"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":584,"sequence_length":584,"sequence_sha256":"ae9762e5a0dffda6d39a80d5698f0cb4b49f821c220b514b19978ae1b182a97a","sequence_start":1,"source_sequence_checksum":"89470badfe9aac3ce1523dcaa5ebd6bd","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":119,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q6J4K2-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q6J4K2-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q6J4K2-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":5450,"format":"json","sha256":"a99d805b291a2da292900f238c61502282334d299260267d74148563329235c3","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.341,"fraction_plddt_low":0.075,"fraction_plddt_very_high":0.462,"fraction_plddt_very_low":0.122,"global_plddt":80.69,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q6J4K2-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2006-01-10"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q6J4K2","structure_class":"predicted target model","structure_id":"S-AF-Q6J4K2-F1","structure_resource_rank":139,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000089060","target_symbol":"SLC8B1","uniprot_accession":"Q6J4K2"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":722,"sequence_length":722,"sequence_sha256":"b57b4616e3364e1fc2a9cc56feee2b3beb83e4d67c007d01efe629fbfddff3ff","sequence_start":1,"source_sequence_checksum":"11d761d6f39293f9a8f96bbee4666e1d","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":120,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q96BD0-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q96BD0-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q96BD0-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":11643,"format":"json","sha256":"1f7a502fb7ee2156c91e3df417fb1106c529524dbc9e40c9c13519fa8199f9cc","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.312,"fraction_plddt_low":0.089,"fraction_plddt_very_high":0.429,"fraction_plddt_very_low":0.17,"global_plddt":77.88,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q96BD0-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2003-01-10"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q96BD0","structure_class":"predicted target model","structure_id":"S-AF-Q96BD0-F1","structure_resource_rank":140,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000101187","target_symbol":"SLCO4A1","uniprot_accession":"Q96BD0"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":459,"sequence_length":459,"sequence_sha256":"0331f76a837610fb95d1477d0c0026a12ecb1d59557ea19271245330335df031","sequence_start":1,"source_sequence_checksum":"cb4ed9eff8739a12416b018bc8bb01ee","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":121,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q687X5-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q687X5-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q687X5-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":4667,"format":"json","sha256":"f04e970ad8218c9ef06d12e9010f7226106cb962bced6bec2dfedb445d602332","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.15,"fraction_plddt_low":0.017,"fraction_plddt_very_high":0.791,"fraction_plddt_very_low":0.041,"global_plddt":90.94,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q687X5-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2004-10-11"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q687X5","structure_class":"predicted target model","structure_id":"S-AF-Q687X5-F1","structure_resource_rank":141,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000127954","target_symbol":"STEAP4","uniprot_accession":"Q687X5"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":416,"sequence_length":416,"sequence_sha256":"f9e95c6de604258303bf521790c38446eac2324bee837d725911f6cbf6a8d5ff","sequence_start":1,"source_sequence_checksum":"a876380d958fd4cdbf93bb4b458f18d9","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":122,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q86T26-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q86T26-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q86T26-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":2555,"format":"json","sha256":"b92c33f6c3a02c576cf46840f4efea6995cc9b175445d59f72f10a0b7060f918","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.147,"fraction_plddt_low":0.026,"fraction_plddt_very_high":0.796,"fraction_plddt_very_low":0.031,"global_plddt":91.56,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q86T26-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2011-01-11"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q86T26","structure_class":"predicted target model","structure_id":"S-AF-Q86T26-F1","structure_resource_rank":142,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000185873","target_symbol":"TMPRSS11B","uniprot_accession":"Q86T26"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":595,"sequence_length":595,"sequence_sha256":"9a61bc3ff7833fc4874fd53fce48683d782bd50295d5d6540448c418af0cf4f1","sequence_start":1,"source_sequence_checksum":"c88ced4cb2bc31aedb8a48f7bead822d","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":123,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P28908-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P28908-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P28908-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":7158,"format":"json","sha256":"e650935182627998eb93fb6c7e7d324359da1ccabd326812811385375f5ebb46","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.173,"fraction_plddt_low":0.119,"fraction_plddt_very_high":0.224,"fraction_plddt_very_low":0.484,"global_plddt":61.22,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P28908-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1992-12-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/P28908","structure_class":"predicted target model","structure_id":"S-AF-P28908-F1","structure_resource_rank":143,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000120949","target_symbol":"TNFRSF8","uniprot_accession":"P28908"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":765,"sequence_length":765,"sequence_sha256":"de54b9165094fbbc9ce6aea67a4d5a27fd2bb142520dfc52151e11ec44f23c69","sequence_start":1,"source_sequence_checksum":"0c37aad283de1f8ddcbeb2cfa6d41c39","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":124,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q9H1D0-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q9H1D0-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q9H1D0-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":5988,"format":"json","sha256":"1486dc8c54ef068fe0a26c73b99e1a253b5a86c3fb58ec434e662db05b9faad4","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.242,"fraction_plddt_low":0.059,"fraction_plddt_very_high":0.541,"fraction_plddt_very_low":0.158,"global_plddt":80.56,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q9H1D0-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2015-04-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q9H1D0","structure_class":"predicted target model","structure_id":"S-AF-Q9H1D0-F1","structure_resource_rank":144,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000165125","target_symbol":"TRPV6","uniprot_accession":"Q9H1D0"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":495,"sequence_length":495,"sequence_sha256":"c3334126628292d093cfd45394f323a3ca2846ccb365862068b5196f3c27f2b4","sequence_start":1,"source_sequence_checksum":"ffe718476ba0c6ac08f763c2fa2e01a5","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":125,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P06127-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P06127-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P06127-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":2703,"format":"json","sha256":"41a48daaa0880a8df5b884167377701807affd4c6c8231f69dcd11f29c8505cb","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.317,"fraction_plddt_low":0.125,"fraction_plddt_very_high":0.325,"fraction_plddt_very_low":0.232,"global_plddt":73.38,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P06127-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2010-11-30"},"source_url":"https://alphafold.ebi.ac.uk/entry/P06127","structure_class":"predicted target model","structure_id":"S-AF-P06127-F1","structure_resource_rank":145,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000110448","target_symbol":"CD5","uniprot_accession":"P06127"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":1156,"sequence_length":1156,"sequence_sha256":"96fdc58597858ba47ca31f55c5a72871b8527f144c181d1b438dbfe6d6cd3cc8","sequence_start":1,"source_sequence_checksum":"a37c239034a365e7888b6804df4d7c5e","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":126,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q86VB7-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q86VB7-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q86VB7-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":15426,"format":"json","sha256":"4f9da45b1a0e0f10e51545fc61041822c861e96bfb95e1c180ca1e756a46d7e8","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.49,"fraction_plddt_low":0.087,"fraction_plddt_very_high":0.286,"fraction_plddt_very_low":0.137,"global_plddt":77.5,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q86VB7-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2010-11-30"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q86VB7","structure_class":"predicted target model","structure_id":"S-AF-Q86VB7-F1","structure_resource_rank":146,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000177575","target_symbol":"CD163","uniprot_accession":"Q86VB7"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":1114,"sequence_length":1114,"sequence_sha256":"10ec8a9e8316e42cd33c02e147ccc5d057ce4ecac76498c455a230ec4485d6be","sequence_start":1,"source_sequence_checksum":"975d8b611319eb0afd1b7f9439f12ab7","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":127,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P07949-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P07949-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P07949-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":7601,"format":"json","sha256":"15a4fb1e2f19f3e905824303ce64d1550df44a201ff451d9084e96553b3eb669","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.264,"fraction_plddt_low":0.039,"fraction_plddt_very_high":0.509,"fraction_plddt_very_low":0.188,"global_plddt":78.81,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P07949-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1994-06-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/P07949","structure_class":"predicted target model","structure_id":"S-AF-P07949-F1","structure_resource_rank":71,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000165731","target_symbol":"RET","uniprot_accession":"P07949"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":535,"sequence_length":535,"sequence_sha256":"72457bd3e469b5da79ef671c8cecc272c88c727382f4cdaae3eea77a773396db","sequence_start":1,"source_sequence_checksum":"7c86f75ac1e63bb59303d147758f3aba","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":128,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P05187-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P05187-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P05187-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":2790,"format":"json","sha256":"18f486a5ba57c388b92c849ab16cbb0bfe942ba17f48e09d92bda345c1e4acfb","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.007,"fraction_plddt_low":0.032,"fraction_plddt_very_high":0.893,"fraction_plddt_very_low":0.067,"global_plddt":93.44,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P05187-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1989-07-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/P05187","structure_class":"predicted target model","structure_id":"S-AF-P05187-F1","structure_resource_rank":147,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000163283","target_symbol":"ALPP","uniprot_accession":"P05187"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":532,"sequence_length":532,"sequence_sha256":"2d43213963de67d768d71ee3edbd337e1d66e34f88a5ef5ebdcbee782cb3980d","sequence_start":1,"source_sequence_checksum":"2384b8303cf754fa1b560afd8a02eeb3","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":129,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P36894-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P36894-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P36894-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":2792,"format":"json","sha256":"ef7070b34f097bfe81acf4b61cbf2b940ac26b4c10fd11c0c51f8f709bb64567","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.252,"fraction_plddt_low":0.113,"fraction_plddt_very_high":0.536,"fraction_plddt_very_low":0.1,"global_plddt":82.62,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P36894-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2005-03-15"},"source_url":"https://alphafold.ebi.ac.uk/entry/P36894","structure_class":"predicted target model","structure_id":"S-AF-P36894-F1","structure_resource_rank":148,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000107779","target_symbol":"BMPR1A","uniprot_accession":"P36894"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":1207,"sequence_length":1207,"sequence_sha256":"545bb1b1a282b1dafa922e03e94dba9cf39e4898b85d59e30bb74d2b0384aca1","sequence_start":1,"source_sequence_checksum":"fc76ad916a9b87ea6db6e57b20f424f3","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":130,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P01133-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P01133-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P01133-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":11733,"format":"json","sha256":"e4f0a6d127b7316797f2509836da2dcadce51cd385d56d20c2b50527840a5efc","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.442,"fraction_plddt_low":0.129,"fraction_plddt_very_high":0.202,"fraction_plddt_very_low":0.227,"global_plddt":70.31,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P01133-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2009-07-07"},"source_url":"https://alphafold.ebi.ac.uk/entry/P01133","structure_class":"predicted target model","structure_id":"S-AF-P01133-F1","structure_resource_rank":149,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000138798","target_symbol":"EGF","uniprot_accession":"P01133"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":984,"sequence_length":984,"sequence_sha256":"30af96ec58c63a9152901077921fd0e3ced59fccc9dfe834e44b5557f3956587","sequence_start":1,"source_sequence_checksum":"1a8896170fbf6efcc913d02d247690c3","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":131,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P54762-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P54762-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P54762-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":8198,"format":"json","sha256":"f22c5491ef1f6c4c6e971ad3a58afccb1f508e3609bbc6f30e7ad3a989ad1aca","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.369,"fraction_plddt_low":0.066,"fraction_plddt_very_high":0.487,"fraction_plddt_very_low":0.078,"global_plddt":83.62,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P54762-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1996-10-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/P54762","structure_class":"predicted target model","structure_id":"S-AF-P54762-F1","structure_resource_rank":150,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000154928","target_symbol":"EPHB1","uniprot_accession":"P54762"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":281,"sequence_length":281,"sequence_sha256":"53a6da74b7f56161c0ca6ecefc9966b7566ee3b75ef1afa0dd752d168b8d4ea0","sequence_start":1,"source_sequence_checksum":"b7a1b1dcf5cc7eb1955310f5758c85ae","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":132,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P48023-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P48023-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P48023-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":4049,"format":"json","sha256":"c48d4dcfc06f1f10d85e4c34e06c60ca7cd21d35111d8b677b9cf78a9c647030","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.139,"fraction_plddt_low":0.171,"fraction_plddt_very_high":0.552,"fraction_plddt_very_low":0.139,"global_plddt":80.19,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P48023-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1996-02-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/P48023","structure_class":"predicted target model","structure_id":"S-AF-P48023-F1","structure_resource_rank":151,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000117560","target_symbol":"FASLG","uniprot_accession":"P48023"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":1073,"sequence_length":1073,"sequence_sha256":"65e0c45e5759303997c3b2d84199fc621c9d3899348c9b6fd17686195676db85","sequence_start":1,"source_sequence_checksum":"52edd741bee5d20fae1a1fd2e903ff7d","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":{"bytes":1035254,"format":"mmcif","sha256":"da8efb11fdf1561ace176eb3a108f9c85105faeb861983dd3316a32a14e369e5","storage":"external-artifact-root"},"priority_selected":true,"retrieved_at":"2026-09-04","source_url":"https://alphafold.ebi.ac.uk/files/AF-P25092-F1-model_v6.cif","state":"reused","transport":"trusted cifUrl file download"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":133,"experimental_structure_ids":["S-RCSB-8GHP"],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P25092-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P25092-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P25092-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":3852,"format":"json","sha256":"bf4fd8af25b5e381ab4f9ac424dcd81477f0aa527f7097748543b72d8d29defd","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.438,"fraction_plddt_low":0.127,"fraction_plddt_very_high":0.351,"fraction_plddt_very_low":0.084,"global_plddt":80.0,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P25092-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2010-11-02"},"source_url":"https://alphafold.ebi.ac.uk/entry/P25092","structure_class":"predicted target model","structure_id":"S-AF-P25092-F1","structure_resource_rank":8,"structure_tier":"structure-a","target_id":"T-ENSG00000070019","target_symbol":"GUCY2C","uniprot_accession":"P25092"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":1012,"sequence_length":1012,"sequence_sha256":"a5127cb14a0d4fb2a5a6e70e8518e096a67aade9c34d1012d1ae5b98c7890c04","sequence_start":1,"source_sequence_checksum":"a171c35f35431dc06e80a0b36b1e5045","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":134,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UEF7-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UEF7-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UEF7-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":6264,"format":"json","sha256":"a53e04f205b88f8026e623e242aa10919b7864a49b4a16f6c25c5ffd9875cfcc","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.175,"fraction_plddt_low":0.041,"fraction_plddt_very_high":0.729,"fraction_plddt_very_low":0.055,"global_plddt":89.06,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q9UEF7-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2005-10-11"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q9UEF7","structure_class":"predicted target model","structure_id":"S-AF-Q9UEF7-F1","structure_resource_rank":152,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000133116","target_symbol":"KL","uniprot_accession":"Q9UEF7"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":313,"sequence_length":313,"sequence_sha256":"4a399e4ae20c6ba514d8857c532cce00298ee2d377c85fc6d0fa2a8259910003","sequence_start":1,"source_sequence_checksum":"bd59f2995e10d8a396682dcc5559921b","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":135,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q8NGD0-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q8NGD0-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q8NGD0-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":2333,"format":"json","sha256":"1721a9e514d3b1cbae1717f8989b29fc39f0f931d14a6966b43f6663b60fda4f","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.284,"fraction_plddt_low":0.026,"fraction_plddt_very_high":0.681,"fraction_plddt_very_low":0.01,"global_plddt":89.69,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q8NGD0-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2002-10-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q8NGD0","structure_class":"predicted target model","structure_id":"S-AF-Q8NGD0-F1","structure_resource_rank":153,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000176299","target_symbol":"OR4M1","uniprot_accession":"Q8NGD0"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":574,"sequence_length":574,"sequence_sha256":"9be4c54332c5ff2a4588d5f6252d037760f1eadab5b8cc22a0f16d28466bcf2d","sequence_start":1,"source_sequence_checksum":"a6f697c1b6392ddd8ab8a98f7000e781","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":136,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P43004-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P43004-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P43004-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":8085,"format":"json","sha256":"e9b1e921be0db93f2eb4d41ab1d522b0f13d7020ba437535a890415923e8d472","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.261,"fraction_plddt_low":0.11,"fraction_plddt_very_high":0.465,"fraction_plddt_very_low":0.164,"global_plddt":77.75,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P43004-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1998-07-15"},"source_url":"https://alphafold.ebi.ac.uk/entry/P43004","structure_class":"predicted target model","structure_id":"S-AF-P43004-F1","structure_resource_rank":154,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000110436","target_symbol":"SLC1A2","uniprot_accession":"P43004"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":577,"sequence_length":577,"sequence_sha256":"acd531523d9a2aac44c2945acf554b17914786d0cf8a28ba812bfcaf421f4b48","sequence_start":1,"source_sequence_checksum":"9444abe62f2b20e3f3316989db967ba2","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":137,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q86VW1-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q86VW1-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q86VW1-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":7963,"format":"json","sha256":"6261eae5bbd584d857c5d86bce149a19a9fa02506ed76df59ca6cbe26ef04d03","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.331,"fraction_plddt_low":0.062,"fraction_plddt_very_high":0.537,"fraction_plddt_very_low":0.069,"global_plddt":84.88,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q86VW1-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2003-06-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q86VW1","structure_class":"predicted target model","structure_id":"S-AF-Q86VW1-F1","structure_resource_rank":155,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000004809","target_symbol":"SLC22A16","uniprot_accession":"Q86VW1"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":160,"sequence_length":160,"sequence_sha256":"d18a89bf2daa95c4bd4d581664e00678a12e814a203cbd84fac5e9425989754c","sequence_start":1,"source_sequence_checksum":"fed2ab2694a476410d61ba4eb2136717","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":138,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P01135-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P01135-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P01135-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":9237,"format":"json","sha256":"14e12f7ed38f4166f9b9d6ea41b8b706874d2984ddeb086737461159ea1d58ce","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.475,"fraction_plddt_low":0.3,"fraction_plddt_very_high":0.0,"fraction_plddt_very_low":0.225,"global_plddt":66.44,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P01135-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1986-07-21"},"source_url":"https://alphafold.ebi.ac.uk/entry/P01135","structure_class":"predicted target model","structure_id":"S-AF-P01135-F1","structure_resource_rank":156,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000163235","target_symbol":"TGFA","uniprot_accession":"P01135"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":183,"sequence_length":183,"sequence_sha256":"021fcbfe8a49f5b28561822ae8edf218c3793e066da31f35cf764dac8a623fcf","sequence_start":1,"source_sequence_checksum":"2a0e441eb2d40da91c9b3b21ae4db5dd","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":139,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P23510-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P23510-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P23510-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":3863,"format":"json","sha256":"5c2888917ae15d56cd96bd812b02d2f5353ebadb95c9d1fc09429743f849443d","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.175,"fraction_plddt_low":0.098,"fraction_plddt_very_high":0.634,"fraction_plddt_very_low":0.093,"global_plddt":84.81,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P23510-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1991-11-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/P23510","structure_class":"predicted target model","structure_id":"S-AF-P23510-F1","structure_resource_rank":157,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000117586","target_symbol":"TNFSF4","uniprot_accession":"P23510"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":1308,"sequence_length":1308,"sequence_sha256":"1d456f9470d2ff57ac97450faa7588aef382adc7eff33d54259187c71584d11a","sequence_start":1,"source_sequence_checksum":"427b0012f5464bdd5b2c4f015a5cb648","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":140,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q15303-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q15303-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q15303-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":16545,"format":"json","sha256":"6c21036bebb9e70d44d262aaf0c7c360d697c4d404eef98f45105891abbb9318","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.227,"fraction_plddt_low":0.063,"fraction_plddt_very_high":0.44,"fraction_plddt_very_low":0.269,"global_plddt":73.12,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q15303-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1996-11-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q15303","structure_class":"predicted target model","structure_id":"S-AF-Q15303-F1","structure_resource_rank":158,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000178568","target_symbol":"ERBB4","uniprot_accession":"Q15303"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":806,"sequence_length":806,"sequence_sha256":"9c4089da85ef3c06dde2c14def7afc4a2e1452947ca9abf34025f90a101db770","sequence_start":1,"source_sequence_checksum":"632616f7ccb30252cd89afba2784beec","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":{"bytes":719724,"format":"mmcif","sha256":"892e34e29d2151f723b4b9dc5f76f9b1b8807457d255e16f455e40ede9480ff4","storage":"external-artifact-root"},"priority_selected":true,"retrieved_at":"2026-09-04","source_url":"https://alphafold.ebi.ac.uk/files/AF-P22607-F1-model_v6.cif","state":"reused","transport":"trusted cifUrl file download"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":141,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P22607-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P22607-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P22607-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":12368,"format":"json","sha256":"213faf221651b152a5d52d7476eebc973ef42d7310de237e5f88430428bdd3bd","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.311,"fraction_plddt_low":0.099,"fraction_plddt_very_high":0.362,"fraction_plddt_very_low":0.227,"global_plddt":74.19,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P22607-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1991-08-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/P22607","structure_class":"predicted target model","structure_id":"S-AF-P22607-F1","structure_resource_rank":39,"structure_tier":"structure-c","target_id":"T-ENSG00000068078","target_symbol":"FGFR3","uniprot_accession":"P22607"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":580,"sequence_length":580,"sequence_sha256":"77dfca719964bc76f8f4a345c1fa314a8b55845c770a272f9b3e2e81f348df23","sequence_start":1,"source_sequence_checksum":"4be0e3de5710eccd6b86576ba6d304a8","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":142,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P51654-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P51654-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P51654-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":8023,"format":"json","sha256":"5124e8c9e343dda9e0cbd27b780e8d73de8e96f695a4df7d6a8ab943fea46565","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.138,"fraction_plddt_low":0.055,"fraction_plddt_very_high":0.522,"fraction_plddt_very_low":0.284,"global_plddt":75.06,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P51654-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1996-10-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/P51654","structure_class":"predicted target model","structure_id":"S-AF-P51654-F1","structure_resource_rank":53,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000147257","target_symbol":"GPC3","uniprot_accession":"P51654"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":650,"sequence_length":650,"sequence_sha256":"4ec1b53535c88046381a722b24bf23a972bb0d628fb28d20fee160b38f130163","sequence_start":1,"source_sequence_checksum":"371bbe855c35fe5ec5edf0f5ff70534d","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":143,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q8NHL6-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q8NHL6-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q8NHL6-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":13641,"format":"json","sha256":"592ee53ccde60431c25c4618d50d8b4337f73369781022de36e8dda0737d3562","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.106,"fraction_plddt_low":0.057,"fraction_plddt_very_high":0.522,"fraction_plddt_very_low":0.315,"global_plddt":73.38,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q8NHL6-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2002-10-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q8NHL6","structure_class":"predicted target model","structure_id":"S-AF-Q8NHL6-F1","structure_resource_rank":159,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000104972","target_symbol":"LILRB1","uniprot_accession":"Q8NHL6"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":325,"sequence_length":325,"sequence_sha256":"f104c7b186d2a003cfbf9dcad6dcb9e8d9383f5d711634ddd85886324e44bd7a","sequence_start":1,"source_sequence_checksum":"a239cfebde6cc0d37bce2fef240c3f97","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":144,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P04201-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P04201-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P04201-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":2350,"format":"json","sha256":"2992e7dd4a9c0c4a5c3c17d9626397f0072929336d0ebc6b9d53a46e23575da3","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.222,"fraction_plddt_low":0.077,"fraction_plddt_very_high":0.591,"fraction_plddt_very_low":0.111,"global_plddt":83.5,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P04201-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1987-03-20"},"source_url":"https://alphafold.ebi.ac.uk/entry/P04201","structure_class":"predicted target model","structure_id":"S-AF-P04201-F1","structure_resource_rank":160,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000130368","target_symbol":"MAS1","uniprot_accession":"P04201"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":348,"sequence_length":348,"sequence_sha256":"b59611b13c3509dcbb28613b8c35f400f97e67788dcf416dce0511a576c347c1","sequence_start":1,"source_sequence_checksum":"d000022e87e6b7b84cccba9baf34568a","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":145,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P08100-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P08100-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P08100-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":2388,"format":"json","sha256":"bac572a2fcbb0d40a9736eb12909c717c4dcbe15d886701f827474808e7b47ed","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.224,"fraction_plddt_low":0.049,"fraction_plddt_very_high":0.678,"fraction_plddt_very_low":0.049,"global_plddt":88.75,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P08100-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1988-08-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/P08100","structure_class":"predicted target model","structure_id":"S-AF-P08100-F1","structure_resource_rank":161,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000163914","target_symbol":"RHO","uniprot_accession":"P08100"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":658,"sequence_length":658,"sequence_sha256":"9d83bcc4b07c00cde894c5077339d6e62f4ef394c3339ce76380957cc320da13","sequence_start":1,"source_sequence_checksum":"a8ee20ef0bc127849fdd30d18a6d90cf","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":{"bytes":581757,"format":"mmcif","sha256":"9ae083ffb320c086efcfe785eda3dd3bcfee0a7821291deea78b825a3255b4a0","storage":"external-artifact-root"},"priority_selected":true,"retrieved_at":"2026-09-04","source_url":"https://alphafold.ebi.ac.uk/files/AF-P17813-F1-model_v6.cif","state":"reused","transport":"trusted cifUrl file download"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":146,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P17813-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P17813-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P17813-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":5707,"format":"json","sha256":"4ec03924dd47a99e3f82fc6be020b14239d385621b38e66b1b9c03e3470537ab","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.406,"fraction_plddt_low":0.081,"fraction_plddt_very_high":0.386,"fraction_plddt_very_low":0.128,"global_plddt":80.06,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P17813-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1998-07-15"},"source_url":"https://alphafold.ebi.ac.uk/entry/P17813","structure_class":"predicted target model","structure_id":"S-AF-P17813-F1","structure_resource_rank":48,"structure_tier":"structure-c","target_id":"T-ENSG00000106991","target_symbol":"ENG","uniprot_accession":"P17813"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":685,"sequence_length":685,"sequence_sha256":"c493b63e299b3245d088ff0cab36a90c477cd90b672953fe71ff07622e4e818e","sequence_start":1,"source_sequence_checksum":"7a131fc7fe9ae04441fdd109b2a5eb9d","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":147,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NR61-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NR61-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NR61-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":3074,"format":"json","sha256":"d2e3ffbbec02ef1928d87426ab67177821961a3f9ed1f5b770698c9fdcac8dc1","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.343,"fraction_plddt_low":0.112,"fraction_plddt_very_high":0.346,"fraction_plddt_very_low":0.199,"global_plddt":74.88,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q9NR61-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2000-10-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q9NR61","structure_class":"predicted target model","structure_id":"S-AF-Q9NR61-F1","structure_resource_rank":73,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000128917","target_symbol":"DLL4","uniprot_accession":"Q9NR61"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":1070,"sequence_length":1070,"sequence_sha256":"ccbd8104cd4096ca3127315d99235a841babf5b8275a7ec7b7316773b5b0636d","sequence_start":1,"source_sequence_checksum":"087a14728360ca3887246a3573fff451","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":148,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q13308-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q13308-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q13308-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":21025,"format":"json","sha256":"7b3b9049db05ee95cd8a3eb96b22f636937a50af9eeeece5a4ef5c3fae988e00","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.379,"fraction_plddt_low":0.048,"fraction_plddt_very_high":0.479,"fraction_plddt_very_low":0.094,"global_plddt":82.69,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q13308-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2006-10-17"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q13308","structure_class":"predicted target model","structure_id":"S-AF-Q13308-F1","structure_resource_rank":57,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000112655","target_symbol":"PTK7","uniprot_accession":"Q13308"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":564,"sequence_length":564,"sequence_sha256":"cd36e0becd7cef67ed39ad1f6b614146a90737cff00d7fae025827a63b65e2ed","sequence_start":1,"source_sequence_checksum":"8976d6808030ecab7ff9f01d1c278a71","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":{"bytes":518595,"format":"mmcif","sha256":"7f1331d8e6536361692c89289ed3e4623263cb65e525a66fa708c26191aef9e2","storage":"external-artifact-root"},"priority_selected":true,"retrieved_at":"2026-09-04","source_url":"https://alphafold.ebi.ac.uk/files/AF-Q9H6X2-F1-model_v6.cif","state":"reused","transport":"trusted cifUrl file download"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":149,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q9H6X2-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q9H6X2-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q9H6X2-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":13969,"format":"json","sha256":"2be54313bad02d11efc4af9e0f4748a08e6ad8307456e47a8b5464aae9a04d7d","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.191,"fraction_plddt_low":0.197,"fraction_plddt_very_high":0.369,"fraction_plddt_very_low":0.243,"global_plddt":72.44,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q9H6X2-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2001-11-02"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q9H6X2","structure_class":"predicted target model","structure_id":"S-AF-Q9H6X2-F1","structure_resource_rank":45,"structure_tier":"structure-c","target_id":"T-ENSG00000169604","target_symbol":"ANTXR1","uniprot_accession":"Q9H6X2"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":760,"sequence_length":760,"sequence_sha256":"fc502b7363283bca3ea0e276ed1d65d0ae8d5064519a226a06f9c77059235b6f","sequence_start":1,"source_sequence_checksum":"ec62f6a5082e8fb9d8eb9114813fc3c5","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":{"bytes":722126,"format":"mmcif","sha256":"5139d5f3a494071c56cf788aa10c21eaf9f346e0ac9becf0e04613752e3fb1df","storage":"external-artifact-root"},"priority_selected":true,"retrieved_at":"2026-09-04","source_url":"https://alphafold.ebi.ac.uk/files/AF-Q12884-F1-model_v6.cif","state":"reused","transport":"trusted cifUrl file download"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":150,"experimental_structure_ids":["S-RCSB-6Y0F","S-RCSB-9DVR"],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q12884-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q12884-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q12884-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":5169,"format":"json","sha256":"ddcb0dcadbf42524358f1646b38e750c309cd7eb7943aa2fd3ccd90159a181e1","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.034,"fraction_plddt_low":0.02,"fraction_plddt_very_high":0.932,"fraction_plddt_very_low":0.014,"global_plddt":95.62,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q12884-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2010-03-23"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q12884","structure_class":"predicted target model","structure_id":"S-AF-Q12884-F1","structure_resource_rank":9,"structure_tier":"structure-a","target_id":"T-ENSG00000078098","target_symbol":"FAP","uniprot_accession":"Q12884"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":278,"sequence_length":278,"sequence_sha256":"0bb64c2c264604736cb55682994d6fc7658581911a587b755f518dc673c57a98","sequence_start":1,"source_sequence_checksum":"ce4d90663dcc5441ad2762730ef685b8","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":151,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P41217-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P41217-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P41217-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":6088,"format":"json","sha256":"3be3c01d01a2a62733ae522bb3a638b2f9b09c1773c8eea1c39aa7b01fb67b3e","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.216,"fraction_plddt_low":0.126,"fraction_plddt_very_high":0.622,"fraction_plddt_very_low":0.036,"global_plddt":86.56,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P41217-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2010-11-02"},"source_url":"https://alphafold.ebi.ac.uk/entry/P41217","structure_class":"predicted target model","structure_id":"S-AF-P41217-F1","structure_resource_rank":75,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000091972","target_symbol":"CD200","uniprot_accession":"P41217"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":894,"sequence_length":894,"sequence_sha256":"0e1b606ba4a2733bcc0bfda24d9072606dc3876638804d08520b6d5c668ea019","sequence_start":1,"source_sequence_checksum":"57cd15357b0cafed33b9be7506be14a6","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":152,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P30530-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P30530-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P30530-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":6754,"format":"json","sha256":"1584cdf479ed00270baa8dc1ee11b2f04380659ed5502637c86bd5c1fad70dfb","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.324,"fraction_plddt_low":0.094,"fraction_plddt_very_high":0.378,"fraction_plddt_very_low":0.204,"global_plddt":75.06,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P30530-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2018-03-28"},"source_url":"https://alphafold.ebi.ac.uk/entry/P30530","structure_class":"predicted target model","structure_id":"S-AF-P30530-F1","structure_resource_rank":76,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000167601","target_symbol":"AXL","uniprot_accession":"P30530"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":757,"sequence_length":757,"sequence_sha256":"5de140e38af6ff4da85214e6fdc7a93faa5b9be0b770eb0329f411900d5588c3","sequence_start":1,"source_sequence_checksum":"48879aa2e9674fbfcc925d665df0f396","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":153,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q9HCU0-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q9HCU0-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q9HCU0-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":5532,"format":"json","sha256":"478302c1310111ee5b7ffde4b32f42b9d93136f15c8f98b0b86d27dc9a974e56","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.164,"fraction_plddt_low":0.086,"fraction_plddt_very_high":0.292,"fraction_plddt_very_low":0.458,"global_plddt":63.47,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q9HCU0-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2001-03-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q9HCU0","structure_class":"predicted target model","structure_id":"S-AF-Q9HCU0-F1","structure_resource_rank":59,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000174807","target_symbol":"CD248","uniprot_accession":"Q9HCU0"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":1338,"sequence_length":1338,"sequence_sha256":"cabcd0382ed2f6481aa338d4235c57b559cc4d1a254f9c9aae6c341230ecaa90","sequence_start":1,"source_sequence_checksum":"899418d99797aa41d4bc8cc50361b11e","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":{"bytes":1271600,"format":"mmcif","sha256":"578703a310646ec282fc97edaa0815e955daa2c04632d629000b7a2ea801e216","storage":"external-artifact-root"},"priority_selected":true,"retrieved_at":"2026-09-04","source_url":"https://alphafold.ebi.ac.uk/files/AF-P17948-F1-model_v6.cif","state":"reused","transport":"trusted cifUrl file download"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":154,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P17948-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P17948-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P17948-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":22210,"format":"json","sha256":"1ef60aa2c277eb8a0ae9d504c4ecd1971b39b65d8d9f7623e6ff7c2143551e70","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.37,"fraction_plddt_low":0.083,"fraction_plddt_very_high":0.311,"fraction_plddt_very_low":0.236,"global_plddt":72.62,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P17948-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2007-04-03"},"source_url":"https://alphafold.ebi.ac.uk/entry/P17948","structure_class":"predicted target model","structure_id":"S-AF-P17948-F1","structure_resource_rank":47,"structure_tier":"structure-c","target_id":"T-ENSG00000102755","target_symbol":"FLT1","uniprot_accession":"P17948"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":595,"sequence_length":595,"sequence_sha256":"59afaf3c8774c9cec06a003e9fa0d1fb1da47637c45ea570236e0ca79b5a0a44","sequence_start":1,"source_sequence_checksum":"b08a72ec79d891a74e52c22d6fa213bc","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":155,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P03372-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P03372-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P03372-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":9708,"format":"json","sha256":"376f38ef69625ca449f28e52c5c6fffe2f3c82f25c6a5966671fc02ad2b3c5ce","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.069,"fraction_plddt_low":0.032,"fraction_plddt_very_high":0.435,"fraction_plddt_very_low":0.464,"global_plddt":66.44,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P03372-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1994-06-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/P03372","structure_class":"predicted target model","structure_id":"S-AF-P03372-F1","structure_resource_rank":162,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000091831","target_symbol":"ESR1","uniprot_accession":"P03372"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":781,"sequence_length":781,"sequence_sha256":"1e713d035af00ae7ec7e42f80259ed46e06120d2d5c617d320c91de02ce4dd1d","sequence_start":1,"source_sequence_checksum":"a00a625595b355216652c9194fabab84","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":156,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P35222-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P35222-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P35222-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":3261,"format":"json","sha256":"7174ae19131ceb530b2ac1b80575de0d1718daa51fb8ebea66f0a0455cba2eda","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.123,"fraction_plddt_low":0.06,"fraction_plddt_very_high":0.63,"fraction_plddt_very_low":0.187,"global_plddt":81.06,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P35222-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1994-02-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/P35222","structure_class":"predicted target model","structure_id":"S-AF-P35222-F1","structure_resource_rank":163,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000168036","target_symbol":"CTNNB1","uniprot_accession":"P35222"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":690,"sequence_length":690,"sequence_sha256":"33ce6c59e28a7373fce51debe32cec8d891ef691c2e77a0655a74040da25eef9","sequence_start":1,"source_sequence_checksum":"16c21d07d36dc8b416ea72769f0b0280","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":157,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-O95436-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-O95436-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-O95436-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":5988,"format":"json","sha256":"3d9aac403b6eff3ce404fc1967369e495d0bd1457027ca601085bbb9da517ed2","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.448,"fraction_plddt_low":0.091,"fraction_plddt_very_high":0.245,"fraction_plddt_very_low":0.216,"global_plddt":72.94,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-O95436-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2010-11-30"},"source_url":"https://alphafold.ebi.ac.uk/entry/O95436","structure_class":"predicted target model","structure_id":"S-AF-O95436-F1","structure_resource_rank":164,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000157765","target_symbol":"SLC34A2","uniprot_accession":"O95436"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":824,"sequence_length":824,"sequence_sha256":"df665a32b583fcffa4eacb9bd8880a0c240f00418d00c7a4a14bac26a4ea8e5b","sequence_start":1,"source_sequence_checksum":"2078388324178b5ea032be8420b908e4","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":{"bytes":758843,"format":"mmcif","sha256":"d92933f5cf6120537376f68ee432216033c2872f62b8876b835d4476bee13684","storage":"external-artifact-root"},"priority_selected":true,"retrieved_at":"2026-09-04","source_url":"https://alphafold.ebi.ac.uk/files/AF-P78536-F1-model_v6.cif","state":"reused","transport":"trusted cifUrl file download"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":158,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P78536-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P78536-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P78536-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":6293,"format":"json","sha256":"72319bb548accbb132e3f122b4644396fb621762459e674512309efdc383bfc6","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.424,"fraction_plddt_low":0.097,"fraction_plddt_very_high":0.249,"fraction_plddt_very_low":0.231,"global_plddt":72.69,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P78536-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1997-05-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/P78536","structure_class":"predicted target model","structure_id":"S-AF-P78536-F1","structure_resource_rank":36,"structure_tier":"structure-c","target_id":"T-ENSG00000151694","target_symbol":"ADAM17","uniprot_accession":"P78536"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":459,"sequence_length":459,"sequence_sha256":"3501ff1a2c34e139907d0b8726e0ce2d830cfc7304472a862525f3428a6a534c","sequence_start":1,"source_sequence_checksum":"8aad44f79eb8a4ecf08ddf34a53e7807","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":{"bytes":415603,"format":"mmcif","sha256":"697c721e69a669b8831ebc79c0b688afb7b9f357f7ad4e2dc7eb6d0b2447425f","storage":"external-artifact-root"},"priority_selected":true,"retrieved_at":"2026-09-04","source_url":"https://alphafold.ebi.ac.uk/files/AF-Q16790-F1-model_v6.cif","state":"reused","transport":"trusted cifUrl file download"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":159,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q16790-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q16790-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q16790-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":2621,"format":"json","sha256":"a845ae34dc6d42b752a96afee1684347d324d4d07ad8ce9636e2f8a51bdca85c","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.041,"fraction_plddt_low":0.087,"fraction_plddt_very_high":0.569,"fraction_plddt_very_low":0.303,"global_plddt":76.56,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q16790-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2005-12-06"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q16790","structure_class":"predicted target model","structure_id":"S-AF-Q16790-F1","structure_resource_rank":49,"structure_tier":"structure-c","target_id":"T-ENSG00000107159","target_symbol":"CA9","uniprot_accession":"Q16790"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":230,"sequence_length":230,"sequence_sha256":"97f250180f7f70c1c54d1c88f26e3d10406679ca7eb9e317376f6259c7da254d","sequence_start":1,"source_sequence_checksum":"23969cd1987668ce234a11e2e24cf169","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":160,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P57739-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P57739-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P57739-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":2153,"format":"json","sha256":"47878cb01a3fe435877b44404e090dfca9e2ebe39985a9c40fad1b200bb49344","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.291,"fraction_plddt_low":0.183,"fraction_plddt_very_high":0.43,"fraction_plddt_very_low":0.096,"global_plddt":79.44,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P57739-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2001-01-11"},"source_url":"https://alphafold.ebi.ac.uk/entry/P57739","structure_class":"predicted target model","structure_id":"S-AF-P57739-F1","structure_resource_rank":165,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000165376","target_symbol":"CLDN2","uniprot_accession":"P57739"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":618,"sequence_length":618,"sequence_sha256":"08655e45c9c70122a1320e3ba4b74aa9d81f6e2598e67d546a928ae5498e801e","sequence_start":1,"source_sequence_checksum":"554b2de60dc9ae8b8cc410482a0b1a70","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":161,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NYJ7-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NYJ7-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NYJ7-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":5578,"format":"json","sha256":"e021e0df935321c492de6f2909291471f541c27bca877dc5d415b9a6174b478a","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.484,"fraction_plddt_low":0.184,"fraction_plddt_very_high":0.057,"fraction_plddt_very_low":0.275,"global_plddt":65.19,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q9NYJ7-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2000-10-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q9NYJ7","structure_class":"predicted target model","structure_id":"S-AF-Q9NYJ7-F1","structure_resource_rank":166,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000090932","target_symbol":"DLL3","uniprot_accession":"Q9NYJ7"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":925,"sequence_length":925,"sequence_sha256":"022c5e46aa4d58f82ea0b1dcb834398f4f1195826519611b0447b8b5e3536ef3","sequence_start":1,"source_sequence_checksum":"68de1d276d67e3877d226a3c4e14ce74","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":162,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P22413-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P22413-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P22413-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":3600,"format":"json","sha256":"886bacc0fb7d0dbf6c6bcf90bc30b933bc62fa1218d1da7101401626aec56996","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.041,"fraction_plddt_low":0.018,"fraction_plddt_very_high":0.852,"fraction_plddt_very_low":0.089,"global_plddt":90.69,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P22413-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2002-09-19"},"source_url":"https://alphafold.ebi.ac.uk/entry/P22413","structure_class":"predicted target model","structure_id":"S-AF-P22413-F1","structure_resource_rank":167,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000197594","target_symbol":"ENPP1","uniprot_accession":"P22413"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":257,"sequence_length":257,"sequence_sha256":"32c0a619bf0594c065d065d7e221ae2f11c85a62b9d2c5337b44f3930ba58400","sequence_start":1,"source_sequence_checksum":"52f74cde0ab0313dcd97a9ab97b766fc","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":163,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P15328-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P15328-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P15328-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":2219,"format":"json","sha256":"16539879c5c6d39a02d1855faed565250472b2442881712c25bc6c6799df8d7f","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.171,"fraction_plddt_low":0.074,"fraction_plddt_very_high":0.755,"fraction_plddt_very_low":0.0,"global_plddt":91.19,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P15328-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1994-06-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/P15328","structure_class":"predicted target model","structure_id":"S-AF-P15328-F1","structure_resource_rank":168,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000110195","target_symbol":"FOLR1","uniprot_accession":"P15328"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":1257,"sequence_length":1257,"sequence_sha256":"5decc8013d23181976e7f7ac6ce215562fad67f012b82010dea68fbc53f7164e","sequence_start":1,"source_sequence_checksum":"a07d49512f6d3b2ba36186b9e9d7a69d","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":164,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P32004-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P32004-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P32004-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":12197,"format":"json","sha256":"7eb26b357daaf0d47e05810d9be898dfe147a56c05de15f9919b0aa82b4c0e50","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.399,"fraction_plddt_low":0.08,"fraction_plddt_very_high":0.382,"fraction_plddt_very_low":0.14,"global_plddt":78.44,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P32004-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1996-10-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/P32004","structure_class":"predicted target model","structure_id":"S-AF-P32004-F1","structure_resource_rank":56,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000198910","target_symbol":"L1CAM","uniprot_accession":"P32004"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":581,"sequence_length":581,"sequence_sha256":"ce37201f3a38d7fa353e7de5dbd53622fc5d0b4eef105502d93abca59834f0f7","sequence_start":1,"source_sequence_checksum":"80fb961ba1ac7d541a676cab9538848c","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":165,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q8TF66-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q8TF66-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q8TF66-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":5550,"format":"json","sha256":"b4c5ad7c90b631143f72cf4a388456c008208a706d6ba48679c5f94018020392","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.06,"fraction_plddt_low":0.021,"fraction_plddt_very_high":0.737,"fraction_plddt_very_low":0.182,"global_plddt":83.56,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q8TF66-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2011-05-31"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q8TF66","structure_class":"predicted target model","structure_id":"S-AF-Q8TF66-F1","structure_resource_rank":86,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000172061","target_symbol":"LRRC15","uniprot_accession":"Q8TF66"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":1400,"sequence_length":1400,"sequence_sha256":"223384aa416b5e9b85eba0bd82b798c35b38f8ae4325c35ff46c78dbac5325ed","sequence_start":1,"source_sequence_checksum":"89d4ae43fa1f929c184cd778d5ddd4c0","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":{"bytes":1305134,"format":"mmcif","sha256":"e51830789091aa3f585dafb4732e3ebe1b23858b0f5b491141094acf02e7cdcf","storage":"external-artifact-root"},"priority_selected":true,"retrieved_at":"2026-09-04","source_url":"https://alphafold.ebi.ac.uk/files/AF-Q04912-F1-model_v6.cif","state":"reused","transport":"trusted cifUrl file download"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":166,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q04912-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q04912-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q04912-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":23904,"format":"json","sha256":"322ecc9a896998bc0ab7e5bbf3790d9374d06bd485e72bdf09eed8fc28b8d16a","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.339,"fraction_plddt_low":0.066,"fraction_plddt_very_high":0.456,"fraction_plddt_very_low":0.138,"global_plddt":80.12,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q04912-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2018-03-28"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q04912","structure_class":"predicted target model","structure_id":"S-AF-Q04912-F1","structure_resource_rank":50,"structure_tier":"structure-c","target_id":"T-ENSG00000164078","target_symbol":"MST1R","uniprot_accession":"Q04912"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":273,"sequence_length":273,"sequence_sha256":"8bd3ab2005bd4b7272fd2bdd6d9a89d9886486c367f37c6ea57925fc49ce5dec","sequence_start":1,"source_sequence_checksum":"f630b4645f0d199dfa538391abf9df1f","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":167,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q9BQ51-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q9BQ51-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q9BQ51-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":5966,"format":"json","sha256":"22b7c33c1a9d9e6bc26b72645fc847134d94c53872b694715d1b929044031832","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.154,"fraction_plddt_low":0.136,"fraction_plddt_very_high":0.663,"fraction_plddt_very_low":0.048,"global_plddt":86.38,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q9BQ51-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2005-05-10"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q9BQ51","structure_class":"predicted target model","structure_id":"S-AF-Q9BQ51-F1","structure_resource_rank":169,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000197646","target_symbol":"PDCD1LG2","uniprot_accession":"Q9BQ51"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":417,"sequence_length":417,"sequence_sha256":"5eb997559ad887073abcb0765b50f62dee93750205c4b1387b6b4dda88b9ffe3","sequence_start":1,"source_sequence_checksum":"cc5673760b92c9731ef9055d95a60fb5","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":168,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P15151-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P15151-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P15151-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":9173,"format":"json","sha256":"49a029c73cd4508321de0b70a291996011eb46f892435d2b3bec6b61e169719d","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.137,"fraction_plddt_low":0.082,"fraction_plddt_very_high":0.664,"fraction_plddt_very_low":0.118,"global_plddt":84.88,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P15151-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1996-02-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/P15151","structure_class":"predicted target model","structure_id":"S-AF-P15151-F1","structure_resource_rank":87,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000073008","target_symbol":"PVR","uniprot_accession":"P15151"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":369,"sequence_length":369,"sequence_sha256":"6001055d0866d9ee2c225eb36b22f1f56726909686411070689b585515e38d7b","sequence_start":1,"source_sequence_checksum":"1976d7f6d4fd016312f85779add2ecea","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":169,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P30874-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P30874-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P30874-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":4639,"format":"json","sha256":"b261993dd50951b08651514831e76a96c7d55bcf6d222d33d9fa28269b89d5e5","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.244,"fraction_plddt_low":0.103,"fraction_plddt_very_high":0.537,"fraction_plddt_very_low":0.117,"global_plddt":81.31,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P30874-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1993-07-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/P30874","structure_class":"predicted target model","structure_id":"S-AF-P30874-F1","structure_resource_rank":170,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000180616","target_symbol":"SSTR2","uniprot_accession":"P30874"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":282,"sequence_length":282,"sequence_sha256":"4ae8545c495dbf569bad2e2c1f9e18fc02fdadf177069eaa45ec0495879c17e3","sequence_start":1,"source_sequence_checksum":"10c79aea96edb93048dfb50d16845b26","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":170,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q7Z7D3-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q7Z7D3-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q7Z7D3-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":7678,"format":"json","sha256":"b12e148bdef018237cf8275402fe841ebd896054d9e0b102cbe5d490f28e6788","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.121,"fraction_plddt_low":0.039,"fraction_plddt_very_high":0.762,"fraction_plddt_very_low":0.078,"global_plddt":88.5,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q7Z7D3-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2003-10-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q7Z7D3","structure_class":"predicted target model","structure_id":"S-AF-Q7Z7D3-F1","structure_resource_rank":171,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000134258","target_symbol":"VTCN1","uniprot_accession":"Q7Z7D3"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":133,"sequence_length":133,"sequence_sha256":"b8a20c41b1334b48eecaf80fb3d3781edeaa8088695a1b3546ee5e250a6b2a27","sequence_start":1,"source_sequence_checksum":"fbb1985a48174a1aa517dcd8a2ce8add","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":171,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-O95868-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-O95868-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-O95868-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":1997,"format":"json","sha256":"ea851b2f39338f1b4a7693007cb85e4604f5793a200964bf616c5590aa43ce15","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.451,"fraction_plddt_low":0.474,"fraction_plddt_very_high":0.0,"fraction_plddt_very_low":0.075,"global_plddt":66.19,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-O95868-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1999-05-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/O95868","structure_class":"predicted target model","structure_id":"S-AF-O95868-F1","structure_resource_rank":172,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000244355","target_symbol":"LY6G6D","uniprot_accession":"O95868"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":690,"sequence_length":690,"sequence_sha256":"8d7d28e32b0e3203deb55f7ad05e3c7011f917935385a100c702f13c4beab68c","sequence_start":1,"source_sequence_checksum":"d13a79ea781d1f3cb5fa16a9bc18a3e8","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":172,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y2P5-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y2P5-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y2P5-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":5814,"format":"json","sha256":"c324676f7cec66fb19f952f180f1b6c23f67073fd4984a7ad99cd9dad4a4b300","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.243,"fraction_plddt_low":0.106,"fraction_plddt_very_high":0.612,"fraction_plddt_very_low":0.039,"global_plddt":86.06,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q9Y2P5-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1999-11-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q9Y2P5","structure_class":"predicted target model","structure_id":"S-AF-Q9Y2P5-F1","structure_resource_rank":173,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000083807","target_symbol":"SLC27A5","uniprot_accession":"Q9Y2P5"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":759,"sequence_length":759,"sequence_sha256":"d09ccefe7c2bfdced1a34d5b22166e6c404cde3a727eb657af6f0552c68bdaf5","sequence_start":1,"source_sequence_checksum":"d8feaf28e2f35b287ff6967600629b94","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":173,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UHB6-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UHB6-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UHB6-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":14006,"format":"json","sha256":"63e3dd9b82cf4617e2e09bee8be5689c83413376c9175925a61f4f15bf3bbfad","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.066,"fraction_plddt_low":0.224,"fraction_plddt_very_high":0.086,"fraction_plddt_very_low":0.625,"global_plddt":51.72,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q9UHB6-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2000-05-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q9UHB6","structure_class":"predicted target model","structure_id":"S-AF-Q9UHB6-F1","structure_resource_rank":174,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000050405","target_symbol":"LIMA1","uniprot_accession":"Q9UHB6"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":1046,"sequence_length":1046,"sequence_sha256":"b606c098eae182300f53c1c144db0b2dcc69e268edb382758e324acb4ebe6ea2","sequence_start":1,"source_sequence_checksum":"afcc7d6ee26996817c6e625a70b536a8","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":174,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-O15294-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-O15294-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-O15294-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":13669,"format":"json","sha256":"4780877c88fc27cc0270a0b3c96cda92d538e56724741bb23535f56edeaa3c3b","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.063,"fraction_plddt_low":0.011,"fraction_plddt_very_high":0.894,"fraction_plddt_very_low":0.032,"global_plddt":93.06,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-O15294-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2005-06-21"},"source_url":"https://alphafold.ebi.ac.uk/entry/O15294","structure_class":"predicted target model","structure_id":"S-AF-O15294-F1","structure_resource_rank":175,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000147162","target_symbol":"OGT","uniprot_accession":"O15294"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":968,"sequence_length":968,"sequence_sha256":"3654c491186ae9d8a1ff3ccfdd2d1fcaa05e4f792654a32899f5896089dc67e8","sequence_start":1,"source_sequence_checksum":"bf86562e0dfa81d73b6f32e3a4a0a704","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":175,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-O60716-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-O60716-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-O60716-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":99757,"format":"json","sha256":"5c7d66f6119d255f69ef393963aff55bb7cf29a42df1238eb22ab961cd22cf47","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.093,"fraction_plddt_low":0.035,"fraction_plddt_very_high":0.403,"fraction_plddt_very_low":0.469,"global_plddt":65.06,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-O60716-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1998-08-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/O60716","structure_class":"predicted target model","structure_id":"S-AF-O60716-F1","structure_resource_rank":176,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000198561","target_symbol":"CTNND1","uniprot_accession":"O60716"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":536,"sequence_length":536,"sequence_sha256":"bfb0c691493b552212f52a3e68ec9d6c2e67dc37339f19b6e71c22fd202292f8","sequence_start":1,"source_sequence_checksum":"b34856872be278010271203e00bee542","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":176,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P12931-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P12931-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P12931-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":7954,"format":"json","sha256":"6d79df371835baac31e17ffa6527203caada14150dc980954eb36d0d02aac355","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.144,"fraction_plddt_low":0.039,"fraction_plddt_very_high":0.662,"fraction_plddt_very_low":0.155,"global_plddt":83.44,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P12931-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2007-01-23"},"source_url":"https://alphafold.ebi.ac.uk/entry/P12931","structure_class":"predicted target model","structure_id":"S-AF-P12931-F1","structure_resource_rank":177,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000197122","target_symbol":"SRC","uniprot_accession":"P12931"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":510,"sequence_length":510,"sequence_sha256":"47dae33285446c4aba143bab37177a3613fd5469c2e26c63c55b73512ce0b218","sequence_start":1,"source_sequence_checksum":"5ab598d8152ba962037204191e0023cb","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":177,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q96NY8-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q96NY8-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q96NY8-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":4609,"format":"json","sha256":"4b3626f4b8a8d41c86306212109055041e5dbd59cfd86dc9b947a55758696839","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.216,"fraction_plddt_low":0.102,"fraction_plddt_very_high":0.525,"fraction_plddt_very_low":0.157,"global_plddt":79.81,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q96NY8-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2001-12-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q96NY8","structure_class":"predicted target model","structure_id":"S-AF-Q96NY8-F1","structure_resource_rank":60,"structure_tier":"retained-unmodeled","target_id":"T-NECTIN4","target_symbol":"NECTIN4","uniprot_accession":"Q96NY8"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":596,"sequence_length":596,"sequence_sha256":"9b7be3df2fd8c9289ad6396363aaca2240281cca7db991584225ca8be77698e4","sequence_start":1,"source_sequence_checksum":"ba5dc9b52fd727bf278b78a99d915b61","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":178,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y250-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y250-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y250-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":16779,"format":"json","sha256":"c825c32ff9a40653fe1db559d583c442bf84c79bcbc8a20ad72aac986b1f549e","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.109,"fraction_plddt_low":0.109,"fraction_plddt_very_high":0.369,"fraction_plddt_very_low":0.413,"global_plddt":68.12,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q9Y250-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2007-01-23"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q9Y250","structure_class":"predicted target model","structure_id":"S-AF-Q9Y250-F1","structure_resource_rank":178,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000061337","target_symbol":"LZTS1","uniprot_accession":"Q9Y250"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":192,"sequence_length":192,"sequence_sha256":"888e83e176548b0610cbf650e95bb62dedbb97fd0759f305a9b2cf55d55a103a","sequence_start":1,"source_sequence_checksum":"60488af4bcd649a6262c763f312b3c06","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":179,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P56559-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P56559-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P56559-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":3995,"format":"json","sha256":"dd05239545d25f7cdd8726d092b2ef9d242c29d728b1ed67631bd9f737eacc93","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.042,"fraction_plddt_low":0.026,"fraction_plddt_very_high":0.896,"fraction_plddt_very_low":0.036,"global_plddt":93.38,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P56559-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1998-12-15"},"source_url":"https://alphafold.ebi.ac.uk/entry/P56559","structure_class":"predicted target model","structure_id":"S-AF-P56559-F1","structure_resource_rank":179,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000188042","target_symbol":"ARL4C","uniprot_accession":"P56559"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":538,"sequence_length":538,"sequence_sha256":"bd2066ba5401010a36293bfa215a576dd5085e781b5d7d4c7b8f8ea76049d215","sequence_start":1,"source_sequence_checksum":"3367ca68f8cc0d18d458ec9ef9f49837","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":180,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q92692-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q92692-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q92692-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"mapping_warning":"UniProt accession recovered from the target-linked discovered-entity surface record","metadata_artifact":{"bytes":5188,"format":"json","sha256":"ca4dc2e0718659dc7b57e505a68f5fd79e6927ae7c7d247322b4039bc5e544f6","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.121,"fraction_plddt_low":0.099,"fraction_plddt_very_high":0.507,"fraction_plddt_very_low":0.273,"global_plddt":75.75,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q92692-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1997-02-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q92692","structure_class":"predicted target model","structure_id":"S-AF-Q92692-F1","structure_resource_rank":180,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000130202","target_symbol":"PVRL2","uniprot_accession":"Q92692"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":1102,"sequence_length":1102,"sequence_sha256":"8caecf83dffab0bac6b72623e6a7428c5a8cc791b0858bcc7f1f4bc67a8bed5b","sequence_start":1,"source_sequence_checksum":"a09c33bf46654db6fad51846f9219e6c","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":181,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P48736-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P48736-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P48736-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":3971,"format":"json","sha256":"31121c61b52ef695a9245719ef2e63f9f525c4887077bba183c18fae148a29ef","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.207,"fraction_plddt_low":0.047,"fraction_plddt_very_high":0.682,"fraction_plddt_very_low":0.064,"global_plddt":87.81,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P48736-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2006-04-04"},"source_url":"https://alphafold.ebi.ac.uk/entry/P48736","structure_class":"predicted target model","structure_id":"S-AF-P48736-F1","structure_resource_rank":181,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000105851","target_symbol":"PIK3CG","uniprot_accession":"P48736"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":1006,"sequence_length":1006,"sequence_sha256":"539cc4601875205af1fd1613a4fdb8147f8f42f7b984edcd1c2182bdb1cdd07f","sequence_start":1,"source_sequence_checksum":"d999520723b2365d2293939612d9ca37","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":182,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q86YT6-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q86YT6-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q86YT6-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":3729,"format":"json","sha256":"18c42bc97bda6b84e2b4523ad7b4c482990c469d8c5975f7d52ebf42c6978b74","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.232,"fraction_plddt_low":0.034,"fraction_plddt_very_high":0.61,"fraction_plddt_very_low":0.124,"global_plddt":83.56,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q86YT6-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2003-06-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q86YT6","structure_class":"predicted target model","structure_id":"S-AF-Q86YT6-F1","structure_resource_rank":182,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000101752","target_symbol":"MIB1","uniprot_accession":"Q86YT6"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":1242,"sequence_length":1242,"sequence_sha256":"93a883fc2b47725bf4e9104e9faba4402f409c0521c0c39ada4751c232e74286","sequence_start":1,"source_sequence_checksum":"dc79eaa5d02340e19f915753f5b22785","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":183,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-P35568-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-P35568-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-P35568-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":4195,"format":"json","sha256":"756aff81116872abf876b7ebc4bf81a3de37e79d065790c0a3f7edaec5672a6f","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.01,"fraction_plddt_low":0.053,"fraction_plddt_very_high":0.16,"fraction_plddt_very_low":0.777,"global_plddt":49.0,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-P35568-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"1994-06-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/P35568","structure_class":"predicted target model","structure_id":"S-AF-P35568-F1","structure_resource_rank":183,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000169047","target_symbol":"IRS1","uniprot_accession":"P35568"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":671,"sequence_length":671,"sequence_sha256":"a5738db82a0d8d4b3b1be01d61879e9adcd8fef0377366ac0d930a850c227edc","sequence_start":1,"source_sequence_checksum":"259f91067e4215f9dc29a11d6cad461f","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":184,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q13546-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q13546-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q13546-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":5830,"format":"json","sha256":"b0283e71ccb39dbf6bbc584ee95a492c054ae469cfb11d97f3c41867a01dc3ac","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.265,"fraction_plddt_low":0.104,"fraction_plddt_very_high":0.322,"fraction_plddt_very_low":0.308,"global_plddt":69.75,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q13546-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2005-02-01"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q13546","structure_class":"predicted target model","structure_id":"S-AF-Q13546-F1","structure_resource_rank":184,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000137275","target_symbol":"RIPK1","uniprot_accession":"Q13546"},{"binding_evidence":false,"claim_ceiling":"predicted monomer target structure; not ligand-bound or interface evidence","construct":{"chain_id":"A","organism":"Homo sapiens","sequence_end":456,"sequence_length":456,"sequence_sha256":"88b72891e4b06f47127efec536e5e44da0f4235794827789251122a59dbbef2d","sequence_start":1,"source_sequence_checksum":"232c13e5cad19a1e46f59c9ec798cc92","tax_id":9606,"uniprot_reviewed":true},"coordinate":{"artifact":null,"priority_selected":false,"state":"metadata-only-not-prioritized"},"evidence_class":"predicted target model","evidence_precedence":"experimental structures remain the higher-evidence tier","evidence_rank":185,"experimental_structure_ids":[],"files":{"cif_url":"https://alphafold.ebi.ac.uk/files/AF-Q8WV28-F1-model_v6.cif","pae_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q8WV28-F1-predicted_aligned_error_v6.json","plddt_document_url":"https://alphafold.ebi.ac.uk/files/AF-Q8WV28-F1-confidence_v6.json"},"interface_evidence":false,"limitations":["The model is a monomer prediction and does not establish an oligomeric state.","The model does not establish ligand binding, a therapeutic epitope, or an interaction interface.","Membrane orientation, glycans, other PTMs, cleavage state, and disease-state conformation require separate review."],"metadata_artifact":{"bytes":7225,"format":"json","sha256":"2768f486e63fe6a5e4d6e31d8a685146c956098b891660630450aa561d38083f","storage":"external-artifact-root"},"metadata_state":"available","prediction":{"fraction_plddt_confident":0.094,"fraction_plddt_low":0.351,"fraction_plddt_very_high":0.224,"fraction_plddt_very_low":0.331,"global_plddt":63.72,"is_complex":false,"provider_id":"GDM","tool":"AlphaFold Monomer v2.0 pipeline"},"source_accession":"AF-Q8WV28-F1","source_database":"AlphaFold Protein Structure Database","source_revision":{"all_versions":[1,2,3,4,5,6],"latest_version":6,"model_created_date":"2025-08-01","sequence_version_date":"2005-11-22"},"source_url":"https://alphafold.ebi.ac.uk/entry/Q8WV28","structure_class":"predicted target model","structure_id":"S-AF-Q8WV28-F1","structure_resource_rank":185,"structure_tier":"retained-unmodeled","target_id":"T-ENSG00000095585","target_symbol":"BLNK","uniprot_accession":"Q8WV28"}],"schema_version":"codex-surface-alphafold-structure-collection/v0.1","selection_policy":{"coordinate_limit":50,"coordinate_scope":"the first targets by ascending structure_resource_rank","experimental_precedence":"deposited experimental structures remain the higher-evidence tier","metadata_scope":"all retained targets with an atlas UniProt accession","primary_model_rule":"matching non-complex AF-<UniProt>-F1 record at latestVersion"},"source":{"api_base":"https://alphafold.ebi.ac.uk/api","entry_url_template":"https://alphafold.ebi.ac.uk/entry/{uniprot_accession}","metadata_transport":"alphafold-skill/scripts/rest_request.py","name":"AlphaFold Protein Structure Database"}}